hg_136690.1

Basic information about the TSS

---

TSS ID: hg_136690.1 Species: human Chr: chr13		Start: 31161856 End: 31161872 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AB003333 Distance: -23 GeneID: 10808 HGNC/MGI_ID: HGNC:16969 UniProt_ID:

Gene_name: heat shock protein family H (Hsp110) member 1 Gene_symbol: HSPH1 Gene_synonyms: HSP105A HSP105B KIAA0201 NY-CO-25 Gene_source: HGNC:16969

TATA-Box annotation

---

Distance to TSS:	40
Nearest PromoterID:	NM_006644
Entrez ID:	10808
Nearest Unigene:	Hs.743267
Nearest Refseq:	NM_006644
Nearest Ensembl:	ENSG00000120694
Gene Name:	heat shock protein family H (Hsp110) member 1
Gene Alias:	HSP105|HSP105A|HSP105B|NY-CO-25
Gene Description:	heat shock protein family H (Hsp110) member 1
Gene Type:	protein-coding
CpG%:	0.085
GC%:	0.641791
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HSPH1 p2@HSPH1 p3@HSPH1 p4@HSPH1 p5@HSPH1 p6@HSPH1
Sample		p1@HSPH1	p2@HSPH1	p3@HSPH1	p4@HSPH1	p5@HSPH1	p6@HSPH1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	48.31	17.34	6.62	5.26	0.78	2.14
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	51.19	20.23	10.72	5.06	0.61	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	45.33	21.41	8.87	5.02	2.51	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	39.92	18.92	7.69	1.66	1.25	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	47.47	21.60	9.00	2.70	1.57	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	36.24	23.26	9.11	2.33	0.78	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	54.91	24.19	13.29	3.70	1.96	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	58.86	24.95	8.96	3.88	1.94	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	54.71	22.01	9.62	4.49	1.50	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	31.88	34.20	10.43	2.90	1.74	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	31.53	31.13	6.87	4.45	0.81	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	37.00	33.34	6.50	4.07	0.81	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	12.25	7.25	2.26	1.61	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	11.88	5.86	2.71	1.50	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	12.95	3.51	1.32	2.85	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.31	6.54	1.76	3.27	0.75	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	9.61	3.93	1.53	1.09	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.70	3.37	0.84	1.27	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	7.46	4.80	2.13	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	8.42	3.16	2.41	1.65	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	11.76	3.88	2.94	2.27	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.88	6.39	2.24	2.42	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.18	5.56	2.20	2.20	0.26	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.41	5.58	2.18	1.70	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	10.84	5.42	1.81	1.29	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.39	6.33	2.53	0.95	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.44	4.95	4.40	2.75	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	13.91	7.31	3.77	2.83	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	9.69	6.62	4.04	1.78	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.85	6.70	3.98	2.71	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	13.82	6.07	2.51	1.47	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.21	9.38	2.93	2.34	1.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.92	9.71	2.11	2.53	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.69	7.75	3.30	3.13	1.15	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.79	7.29	2.99	1.68	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	11.50	7.47	3.83	1.15	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.06	7.77	3.07	4.70	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	14.31	7.46	4.03	1.81	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	20.26	7.02	4.86	2.16	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	14.16	7.20	4.32	3.12	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	9.41	9.18	3.53	1.65	0.94	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	14.20	11.27	4.10	3.07	0.44	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	15.61	6.54	2.53	2.32	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	11.01	10.49	3.15	1.57	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	15.46	7.43	3.41	2.81	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	17.68	10.93	3.49	3.02	1.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	13.19	7.68	2.88	1.44	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	13.71	11.03	5.07	2.68	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.88	8.38	3.35	3.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	9.10	6.07	3.64	3.44	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	10.45	8.81	3.07	3.28	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.45	9.78	3.78	3.11	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	83.95	27.98	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.94	8.87	2.84	2.13	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.58	5.30	2.65	1.66	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	20.97	12.58	10.07	9.23	0.00	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	9.64	5.51	4.13	3.21	1.38	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.96	4.86	1.94	3.24	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.99	4.82	1.61	2.89	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	12.26	10.37	3.14	7.23	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	8.46	3.53	0.00	1.41	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	8.97	2.24	1.12	0.00	1.68	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	5.57	9.55	1.59	6.37	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	5.78	7.47	1.02	2.38	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	6.50	2.92	1.95	1.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.52	4.97	2.48	2.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	32.33	16.16	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	47.38	15.79	23.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	6.83	5.85	0.49	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.43	4.96	1.49	2.48	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.97	5.16	1.41	1.41	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	7.95	6.95	1.32	0.99	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	6.81	4.02	0.62	1.24	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.64	3.06	1.53	2.45	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	7.92	8.71	3.48	4.28	0.63	0.32
Adipocyte - breast, donor2	11327-117E4	7.54	8.02	1.44	2.89	0.64	0.00
Adipocyte - omental, donor1	11473-119C6	6.11	8.91	2.16	5.60	0.76	0.64
Adipocyte - omental, donor2	11474-119C7	3.74	3.74	0.75	3.74	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	3.35	3.68	0.67	6.70	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	4.47	3.83	3.19	3.83	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	0.00	1.10	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	15.81	8.58	3.16	3.61	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	2.78	1.56	0.17	3.48	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	10.37	7.04	2.93	7.82	1.17	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	10.04	7.21	2.06	3.60	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	17.56	11.99	1.12	3.07	0.84	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	11.76	3.53	1.18	2.35	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	18.58	10.30	3.54	8.04	0.88	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	10.97	8.39	0.32	3.87	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	6.93	4.80	0.53	2.13	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	8.90	6.12	3.90	2.23	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	3.74	3.33	0.42	3.33	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	8.54	6.28	1.51	1.76	0.75	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	11.45	7.20	1.96	3.93	1.96	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	11.27	4.87	2.13	2.13	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	7.96	3.09	1.33	1.33	0.22	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	3.59	1.43	0.72	0.72	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	9.89	4.68	2.52	1.98	0.36	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	0.00	3.35	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.11	2.67	0.41	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	5.03	2.40	1.37	1.60	0.00	0.46
Anulus Pulposus Cell, donor2	11463-119B5	2.94	0.49	0.98	0.98	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.83	8.99	5.84	1.80	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	22.14	6.08	7.81	0.87	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	8.56	4.28	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	24.21	8.97	3.29	2.39	0.90	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	13.91	5.06	2.53	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	17.82	2.64	1.98	0.00	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.49	7.80	3.25	2.27	0.97	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	24.76	7.77	3.88	2.43	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	21.97	8.31	1.78	1.19	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	22.22	8.29	5.27	1.88	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	25.40	9.43	1.45	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	22.57	2.51	6.27	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	27.84	11.86	7.91	2.47	1.81	1.81
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	8.19	6.82	2.73	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	19.00	9.95	7.54	1.81	0.60	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.54	11.25	4.82	3.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	15.68	8.69	4.53	1.89	1.32	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.90	6.15	4.54	1.07	1.07	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	16.58	11.71	2.93	0.98	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	16.59	5.47	3.98	2.16	0.33	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	2.40	1.20	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	10.62	10.62	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	19.38	8.40	5.66	1.72	0.34	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	20.87	7.77	4.37	2.91	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	22.77	7.97	4.93	3.04	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	16.96	8.48	1.21	0.00	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	11.97	9.69	5.70	1.71	0.00	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	24.80	7.91	4.92	1.28	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	15.49	5.68	4.90	1.29	0.26	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	17.83	8.91	4.22	2.35	0.94	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	21.22	9.97	3.54	1.93	0.96	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	12.13	7.13	6.42	4.28	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	18.13	4.68	5.85	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	21.08	6.92	3.61	2.11	0.00	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	2.38	4.75	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	16.27	9.15	4.07	1.02	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.26	7.39	7.39	1.53	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.88	8.26	3.81	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.12	6.47	6.04	1.29	0.43	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	14.82	5.72	3.18	3.18	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.89	6.09	4.35	1.74	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	19.84	8.50	1.89	1.89	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	16.78	10.17	3.05	1.70	0.34	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	2.32	6.95	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	2.11	2.11	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	18.01	5.79	3.86	1.07	0.21	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.03	8.42	4.81	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	14.58	6.56	2.19	2.92	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	20.92	8.74	2.76	2.30	0.92	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	10.20	7.65	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	25.93	16.02	4.83	1.27	1.02	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.13	8.46	5.16	2.06	0.62	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	19.89	6.12	4.90	1.53	1.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	20.08	10.99	2.39	0.96	0.48	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	17.07	7.98	5.10	1.33	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	4.58	3.05	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	19.39	11.63	7.20	2.77	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	23.83	10.59	6.36	1.32	0.26	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.99	5.82	3.27	1.45	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	6.26	2.82	0.74	2.33	0.12	0.37
Astrocyte - cerebellum, donor2	11580-120F5	6.50	1.88	0.68	0.68	0.34	0.34
Astrocyte - cerebellum, donor3	11661-122F5	1.26	0.84	0.21	1.05	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	13.94	17.08	7.67	6.97	3.49	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	39.47	24.27	7.60	8.90	2.75	2.75
Astrocyte - cerebral cortex, donor3	11392-118C6	21.78	20.58	4.47	7.61	1.04	1.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	47.59	21.90	11.47	17.20	3.44	1.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	74.79	38.34	16.41	18.04	3.51	1.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	63.04	32.20	12.63	18.66	4.21	1.82
Basophils, donor1	12241-129G9	13.86	6.80	4.71	0.78	0.78	0.00
Basophils, donor2	12242-129H1	30.31	18.76	21.65	5.41	1.80	0.00
Basophils, donor3	12243-129H2	15.73	6.32	4.85	1.62	0.59	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	1.51	1.08	1.29	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	0.46	0.91	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.20	1.88	1.26	4.39	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	9.57	2.91	1.46	0.83	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	2.53	1.38	1.15	1.61	0.00	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	8.46	3.78	3.60	1.80	0.54	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	85.95	39.68	14.63	5.15	3.81	1.44
Burkitt's lymphoma cell line:RAJI	10476-106I8	86.41	38.43	21.19	13.04	3.03	6.75
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	7.67	5.76	3.52	6.08	0.96	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	10.34	20.68	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	11.83	11.27	7.89	2.25	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	11.14	5.20	7.61	0.93	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	14.05	6.15	6.59	2.41	0.66	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	15.85	17.83	5.09	7.08	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	25.02	20.09	3.79	7.58	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	24.98	20.05	3.62	11.18	1.64	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	13.73	3.76	2.75	1.45	0.43	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	22.33	3.32	1.51	0.91	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	87.41	7.11	3.32	2.37	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	49.55	7.20	4.18	0.84	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	74.80	13.25	9.11	0.83	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	155.45	21.82	11.40	0.50	1.98	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	44.84	8.03	3.52	0.20	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	61.60	11.40	7.48	0.53	0.71	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	162.79	13.71	10.01	0.87	1.09	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	96.46	12.17	5.85	0.23	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	202.23	23.23	13.20	1.58	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	208.56	11.09	8.87	1.11	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	18.15	3.27	2.23	0.30	0.45	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	34.72	9.98	4.19	0.80	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	105.35	10.83	8.74	1.25	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	21.51	3.66	1.83	0.92	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	49.09	11.08	4.07	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	116.54	7.86	4.36	0.87	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	17.75	5.38	4.30	1.34	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	41.87	6.28	5.41	0.87	0.17	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	113.62	5.89	8.84	0.84	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	10.84	2.39	0.92	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	36.64	9.86	3.52	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	87.75	9.21	7.90	0.00	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	80.39	15.17	7.32	0.17	0.52	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	67.65	8.92	4.83	1.49	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	132.13	18.97	10.99	0.43	0.86	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	15.97	2.05	2.05	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	49.60	7.42	4.87	0.00	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	98.13	7.19	8.58	0.70	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	13.08	5.67	2.83	3.49	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	9.24	5.08	1.15	3.46	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	10.40	3.90	1.52	3.25	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	4.05	2.18	0.78	3.74	0.31	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	2.27	2.45	0.17	3.32	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	2.68	2.23	0.67	3.34	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	13.52	10.21	1.79	2.30	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	16.03	5.93	2.42	4.61	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	16.21	8.84	2.53	3.79	1.26	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	16.26	2.03	6.10	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	13.56	13.56	9.49	4.75	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	18.64	15.53	7.25	7.25	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	21.32	30.92	9.06	6.93	3.20	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	16.08	16.08	5.90	5.90	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	10.53	14.04	7.02	4.91	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	17.26	9.41	6.27	6.27	3.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	22.41	10.55	14.50	1.32	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	28.77	19.73	18.08	7.40	2.47	0.00
CD19+ B Cells, donor2	11624-122B4	26.12	18.14	13.78	0.73	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	23.73	17.16	19.18	3.53	1.51	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	54.55	19.39	11.72	9.29	1.62	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	46.74	14.78	5.19	7.19	1.20	0.00
CD34+ Progenitors, donor1	11545-120B6	6.02	3.01	1.00	3.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	24.16	9.55	17.42	5.62	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	11.65	7.14	2.25	11.27	1.13	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	13.30	11.05	2.93	8.12	1.35	0.00
CD4+ T Cells, donor1	11225-116C1	77.84	52.13	71.41	7.86	3.21	0.36
CD4+ T Cells, donor2	11306-117C1	66.75	47.76	45.93	4.90	2.45	0.00
CD4+ T Cells, donor3	11382-118B5	76.25	52.76	50.02	5.49	4.88	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	11.74	5.36	4.34	9.19	0.77	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	12.13	7.86	6.29	8.09	0.45	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	8.62	6.90	5.75	5.46	1.44	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	52.15	68.27	46.94	7.11	6.16	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	40.03	43.54	24.58	4.21	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	26.37	26.37	9.89	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	9.68	5.64	7.37	4.77	1.01	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	13.56	10.68	7.12	2.88	0.51	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	8.54	6.93	5.64	3.06	0.48	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	19.28	18.83	14.79	4.93	1.79	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	10.83	9.78	6.29	6.99	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	14.52	12.32	6.60	7.48	1.76	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	9.70	7.59	2.95	6.75	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	6.44	5.19	2.91	3.95	1.04	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	8.35	4.34	2.34	1.34	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	48.13	53.30	42.15	8.70	3.54	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	32.16	32.16	26.80	6.97	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	46.62	26.90	19.73	3.59	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	15.76	8.90	6.12	6.68	0.19	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	10.18	9.75	6.72	5.63	0.65	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	8.20	11.77	6.30	5.25	1.47	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	40.95	39.94	22.25	6.57	3.54	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	45.92	34.66	32.93	4.77	3.90	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	33.56	35.74	16.13	8.72	3.49	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	17.82	16.83	9.90	10.89	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	14.77	11.08	8.31	12.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	15.35	19.54	4.19	9.77	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	20.77	14.95	8.31	14.95	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	22.58	16.44	10.06	13.50	0.74	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	16.94	15.40	7.70	12.32	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	22.56	14.32	6.09	12.18	1.07	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	15.23	20.77	4.15	13.85	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	124.08	80.54	82.83	6.88	8.51	0.00
CD8+ T Cells, donor2	11307-117C2	121.64	55.19	67.58	4.51	3.38	0.38
CD8+ T Cells, donor3	11383-118B6	115.39	56.81	61.61	5.30	4.29	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	47.94	14.68	10.55	2.98	0.69	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	51.76	17.49	7.91	4.31	0.72	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	49.52	16.42	9.03	5.47	0.55	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	40.83	13.21	7.81	7.81	0.60	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	32.40	13.68	9.60	5.04	0.72	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	37.06	13.87	6.59	3.87	0.91	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	69.31	17.60	16.51	2.61	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	61.06	13.16	14.48	1.58	1.05	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	74.11	19.93	17.35	3.05	0.70	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	36.23	12.98	9.66	3.02	0.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	32.54	13.36	13.07	3.49	0.58	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	46.89	18.12	13.32	4.53	0.27	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	80.55	17.07	19.26	1.75	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	95.64	17.31	17.76	2.28	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	78.32	13.43	12.68	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	38.90	15.13	8.28	3.60	1.80	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	30.79	14.96	8.06	3.45	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	30.88	12.26	8.25	3.54	1.41	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	95.07	24.72	18.70	6.97	0.95	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	83.04	23.07	19.07	5.84	0.31	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	73.09	21.16	16.99	3.53	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	49.34	12.62	12.24	3.44	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	48.47	16.16	15.76	3.94	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	46.90	15.88	9.83	3.78	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	131.68	19.27	19.27	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	123.80	15.39	25.88	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	132.23	12.02	23.04	1.00	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	7.31	0.00	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	8.89	7.91	4.45	3.46	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	5.68	5.68	1.79	5.58	0.32	0.63
Chondrocyte - de diff, donor1	11261-116G1	16.29	11.44	1.73	6.59	1.04	1.04
Chondrocyte - de diff, donor2	11338-117F6	2.84	5.33	0.36	1.07	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	4.21	2.96	1.71	3.30	0.34	0.34
Chondrocyte - re diff, donor2	11339-117F7	9.85	7.16	5.37	0.90	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	4.04	5.66	1.21	1.62	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	16.41	15.95	4.36	6.43	2.18	1.03
Ciliary Epithelial Cells, donor2	11323-117D9	12.18	12.61	4.28	4.49	1.28	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	18.50	13.63	5.22	5.75	1.42	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	39.71	18.07	5.69	6.33	2.02	3.48
Corneal Epithelial Cells, donor1	11526-119I5	2.63	0.66	0.00	0.66	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	6.83	2.28	0.00	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.39	1.28	1.79	0.77	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	77.93	64.55	34.67	2.48	2.81	1.49
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	82.95	79.80	41.63	3.47	3.78	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	62.11	48.31	24.15	6.90	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	50.97	35.85	15.87	3.67	3.02	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	7.52	9.57	5.81	3.42	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	11.10	9.14	5.22	4.57	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	8.23	6.78	6.78	5.32	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	9.51	5.67	3.00	3.34	0.17	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	11.74	4.11	1.76	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	7.35	4.81	1.13	0.57	0.28	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	9.44	7.08	6.29	1.97	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	7.85	8.14	1.75	0.87	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	14.12	8.94	3.76	4.71	1.65	0.24
Endothelial Cells - Artery, donor3	11413-118E9	15.25	8.77	3.16	4.38	0.35	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	24.38	23.27	10.20	2.44	0.89	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	35.60	24.65	13.08	5.17	0.91	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	21.14	18.32	10.15	5.36	1.41	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	8.32	6.83	2.38	0.89	0.00	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	13.54	5.21	6.77	0.52	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	5.96	8.08	2.27	1.13	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	23.21	10.00	3.60	3.60	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	9.96	2.62	0.52	1.57	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	37.15	23.73	8.70	10.06	2.36	1.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	16.51	10.21	4.56	5.00	0.65	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	32.73	14.41	7.08	6.84	0.98	0.12
Endothelial Cells - Vein, donor1	11267-116G7	9.10	5.69	2.28	4.55	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	13.97	4.19	2.79	2.10	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	12.87	5.65	4.24	3.61	0.79	0.47
Eosinophils, donor1	12244-129H3	30.49	30.49	30.49	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	9.90	4.95	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	39.24	3.57	17.83	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1.71	0.24	0.73	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	3.28	2.05	2.05	1.23	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.53	5.15	2.52	0.99	0.33	0.99
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	7.37	2.60	1.30	1.84	0.43	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	13.95	10.79	4.49	4.12	1.09	1.58
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	59.50	36.03	23.88	8.46	3.00	1.91
Fibroblast - Aortic Adventitial, donor2	11326-117E3	11.29	5.91	3.48	3.48	1.37	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	28.46	15.55	4.74	6.59	0.79	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	19.27	6.64	3.65	3.65	1.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	9.98	4.99	2.27	3.63	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	7.58	3.03	0.00	0.00	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	5.68	4.42	1.42	2.21	0.00	0.79
Fibroblast - Cardiac, donor4	11452-119A3	18.49	8.18	5.76	8.49	1.82	0.61
Fibroblast - Cardiac, donor5	11456-119A7	12.06	6.60	4.44	6.09	0.89	0.63
Fibroblast - Cardiac, donor6	11460-119B2	26.68	10.91	7.12	4.24	0.61	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	4.29	3.08	0.67	1.21	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	5.18	3.45	1.73	1.29	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	4.39	0.00	1.46	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	0.46	0.23	0.46	2.54	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	10.01	3.73	2.20	2.88	0.68	0.17
Fibroblast - Dermal, donor1	11269-116G9	7.75	5.40	3.05	4.70	0.70	0.94
Fibroblast - Dermal, donor2	11346-117G5	5.19	8.96	2.83	2.83	0.94	0.47
Fibroblast - Dermal, donor3	11418-118F5	7.25	4.71	1.93	4.11	0.48	0.36
Fibroblast - Dermal, donor4	11450-119A1	21.14	7.01	1.58	8.70	0.34	1.02
Fibroblast - Dermal, donor5	11454-119A5	31.05	11.34	2.27	11.17	1.05	1.57
Fibroblast - Dermal, donor6	11458-119A9	34.11	13.32	4.55	11.37	0.65	2.44
Fibroblast - Gingival, donor1	11237-116D4	10.00	6.25	3.12	5.21	1.04	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	7.60	4.98	4.45	3.14	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	20.03	11.99	2.37	7.64	1.98	1.05
Fibroblast - Gingival, donor3	11394-118C8	6.48	4.45	2.13	6.48	0.39	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	8.31	4.16	3.12	4.16	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	4.05	3.52	1.06	3.35	1.06	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	27.44	10.29	4.83	5.92	1.71	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.85	5.68	4.06	3.11	0.68	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.06	8.12	3.88	2.12	1.41	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	11.85	6.58	3.95	4.83	1.32	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	12.68	8.18	4.77	4.09	0.82	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	24.68	9.87	3.62	4.83	1.21	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	6.02	3.52	0.73	3.82	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	0.00	0.00	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	13.43	10.45	4.48	8.95	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	9.71	4.43	2.53	4.64	0.84	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	2.50	0.83	0.00	1.67	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.84	0.00	0.00	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	11.37	3.25	1.22	4.06	0.81	0.41
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	29.68	16.88	2.91	6.79	1.75	2.13
Fibroblast - Periodontal Ligament, donor2	11319-117D5	33.52	16.84	3.34	8.34	1.06	1.52
Fibroblast - Periodontal Ligament, donor3	11395-118C9	26.62	13.77	7.34	13.16	0.61	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	7.25	1.53	0.76	5.34	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	8.10	3.78	0.81	2.70	0.54	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	7.89	7.07	1.86	3.36	0.12	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	23.32	12.05	5.64	4.20	0.77	1.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	8.13	5.89	3.45	1.83	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2.00	2.00	0.00	2.00	0.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	3.16	1.58	0.40	2.77	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	35.72	12.90	6.75	6.15	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	4.97	4.26	1.24	3.37	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	7.29	6.70	2.96	3.94	0.59	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	30.99	12.34	4.51	3.91	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	10.04	4.53	2.59	6.05	0.32	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	17.46	5.06	6.58	5.57	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	4.59	4.76	2.95	3.94	0.00	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	53.94	21.86	15.24	11.03	2.01	1.20
Fibroblast - skin normal, donor2	11561-120D4	13.46	6.03	2.31	4.22	0.50	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.69	11.79	6.35	8.46	1.21	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	6.30	4.47	3.07	4.89	0.75	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	9.92	3.59	4.44	5.13	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	25.62	9.85	3.94	4.93	0.33	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	20.67	8.31	5.33	6.71	0.75	1.38
Fibroblast - skin walker warburg, donor1	11554-120C6	12.48	5.74	4.05	3.88	0.51	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	4.08	2.82	1.73	2.82	0.16	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	177.28	22.16	0.00	0.00	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	7.84	4.36	1.74	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	48.02	25.48	16.82	2.77	2.60	3.47
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	47.88	22.90	13.01	2.60	1.82	2.60
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	48.29	20.95	17.89	4.09	1.53	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	19.14	16.08	2.30	2.30	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.16	11.49	5.10	2.55	1.28	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	38.51	23.39	2.85	15.97	0.86	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	13.79	17.10	3.03	11.58	0.83	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	21.69	11.87	2.05	4.79	0.68	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	21.60	17.44	4.16	8.52	0.79	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	15.60	13.75	2.64	6.87	0.79	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	30.66	14.35	6.52	5.87	0.33	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	35.38	26.09	5.75	14.15	1.33	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	21.06	10.03	4.52	7.77	0.71	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	37.31	11.82	6.16	5.30	1.11	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	18.80	13.43	4.84	3.49	0.54	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	24.41	13.26	4.71	5.82	1.12	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	28.10	13.84	2.49	7.06	0.97	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.45	8.54	2.03	4.88	0.81	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	19.85	15.06	5.48	3.65	0.23	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	33.01	13.33	6.35	4.11	0.87	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	19.02	13.11	5.46	4.59	1.09	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	15.36	13.89	5.02	2.07	0.89	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	34.18	15.74	4.93	5.72	0.64	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	23.68	15.64	3.35	5.36	2.01	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	20.16	11.69	2.62	5.04	1.21	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	31.72	15.95	4.92	6.11	1.53	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	40.79	26.87	10.29	7.54	2.48	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	28.30	19.98	5.72	5.93	2.39	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.59	16.22	5.12	5.81	1.02	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	26.34	14.38	5.31	5.42	1.11	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.86	25.29	9.98	7.82	1.41	1.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.38	20.62	8.78	6.33	1.02	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	17.74	13.20	2.68	3.51	0.41	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	23.17	12.80	3.57	7.03	0.92	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	19.68	16.68	4.17	4.00	0.50	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	9.48	11.68	3.75	3.31	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	35.05	19.19	4.67	7.13	2.09	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	21.07	18.15	4.86	4.70	1.78	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	16.36	15.72	2.57	2.89	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	21.22	12.51	3.22	4.74	1.33	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.76	13.44	2.69	5.06	1.11	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	15.51	15.51	4.26	3.04	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	32.72	20.28	9.09	4.60	1.25	1.25
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	11.42	13.39	4.83	3.29	2.20	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	19.08	17.39	6.17	6.17	1.68	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	37.87	22.31	8.61	4.81	2.31	1.39
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	31.55	15.78	8.02	2.94	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	33.81	29.99	12.70	4.13	1.84	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	42.49	25.26	10.62	4.92	1.04	1.17
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	16.54	17.89	5.15	3.52	0.81	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.59	18.44	4.61	4.98	1.47	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	15.35	15.79	5.92	2.63	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	12.89	12.89	5.95	4.96	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	21.11	14.38	3.83	4.35	0.40	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	19.57	12.31	4.04	5.25	0.61	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	21.35	22.37	5.85	5.59	1.78	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	37.62	21.30	8.96	14.73	0.80	3.78
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	31.12	17.26	3.24	9.40	1.69	1.69
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	28.85	15.75	5.32	15.75	0.82	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	34.11	15.33	9.07	2.50	1.25	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	32.49	17.52	6.78	8.76	1.41	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	24.44	14.30	3.23	7.84	1.38	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	47.02	14.85	2.47	4.95	4.95	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	39.45	17.41	6.96	5.80	1.93	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	56.16	19.25	3.21	6.42	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	20.87	10.43	5.22	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	43.94	19.20	6.18	5.53	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	32.53	17.71	8.24	7.41	1.24	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	3.33	6.66	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	25.45	18.46	6.15	6.99	2.52	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	35.95	18.63	6.21	5.23	0.98	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	26.00	11.74	5.87	6.71	3.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	29.90	16.86	7.32	6.04	1.27	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	31.59	16.98	5.43	4.76	1.70	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	14.62	12.53	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	23.48	16.61	4.58	8.59	1.15	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	14.80	8.88	2.66	1.48	1.18	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	35.58	8.47	1.69	6.78	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	32.31	19.47	5.38	7.04	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	29.46	17.72	4.37	4.14	2.07	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	10.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	17.30	8.84	5.00	4.61	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	14.02	9.78	3.59	2.61	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	11.37	5.35	2.01	3.34	0.67	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	11.17	11.56	2.70	1.93	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	45.53	18.83	10.27	6.50	4.11	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	19.88	22.36	12.42	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	14.16	8.49	3.30	3.77	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	12.67	9.05	2.41	6.64	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	21.36	6.10	2.03	4.07	1.02	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	16.75	4.79	3.99	1.60	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	15.29	9.87	3.95	3.95	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	11.80	20.07	3.54	5.90	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	13.42	13.42	0.58	2.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	29.41	11.41	6.14	2.19	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	17.80	6.78	2.54	2.54	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	10.15	10.15	2.98	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	15.04	10.19	5.34	3.40	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	2.28	7.99	0.00	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	2.08	2.08	0.42	4.16	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	2.25	1.12	0.00	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6.98	3.17	0.63	2.22	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	1.67	2.92	0.42	1.67	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	22.63	11.72	5.11	2.67	0.35	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	26.33	15.53	5.40	3.38	0.51	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	37.08	13.65	7.05	2.50	1.14	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	21.86	12.46	4.48	3.94	0.66	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	22.78	12.46	6.45	3.22	0.86	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	28.42	12.70	4.31	2.80	0.65	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	22.79	11.08	7.85	2.74	0.62	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	21.62	13.72	4.80	1.54	0.51	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	24.03	13.14	4.81	3.20	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	2.80	1.12	0.56	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.19	0.87	1.30	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	18.51	5.29	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.23	1.76	1.06	2.47	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	3.63	0.73	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	14.16	8.22	2.97	4.55	0.35	0.70
Hepatocyte, donor1	11523-119I2	15.74	4.84	3.63	3.63	0.00	0.00
Hepatocyte, donor2	11603-120I1	18.31	6.46	3.23	3.23	0.00	0.00
Hepatocyte, donor3	11684-122I1	77.92	9.82	2.45	4.91	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	56.78	27.41	7.18	7.18	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	32.68	29.71	9.79	3.67	1.22	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	14.41	6.59	2.61	4.80	0.41	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	9.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	1.38	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	2.56	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	4.57	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	9.75	1.62	6.50	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	0.00	5.00	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	10.89	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	13.23	2.65	1.32	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	0.00	1.11	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	5.24	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.71	1.89	3.15	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	1.55	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	13.57	3.88	1.94	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	8.05	1.61	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	15.48	3.26	2.44	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	3.78	4.62	2.10	0.84	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	9.64	3.21	4.02	2.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	3.69	0.00	2.77	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.02	0.94	1.89	1.42	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	7.26	0.91	1.81	1.81	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	11.84	6.46	5.38	2.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	5.08	1.27	2.54	3.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	7.65	1.91	1.28	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	14.58	0.00	3.65	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.85	2.86	2.14	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	9.88	3.09	2.78	0.93	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	3.51	1.76	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	3.14	12.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	14.60	5.56	4.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	9.73	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	3.49	3.49	0.87	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	0.00	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1.39	2.77	1.39	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00	2.85	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	0.92	2.76	0.00	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	0.00	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	17.54	11.91	5.79	3.26	1.06	2.45
Keratinocyte - epidermal, donor2	11349-117G8	1.76	4.69	0.59	1.76	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	28.11	13.06	5.87	4.35	0.85	1.51
Keratinocyte - oral, donor1	11251-116E9	13.28	9.88	7.15	6.47	0.45	0.23
Keratocytes, donor1	11527-119I6	1.72	0.69	0.69	3.09	0.00	0.00
Keratocytes, donor2	11607-120I5	7.03	1.17	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	4.35	3.75	1.38	4.54	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	6.59	6.59	2.20	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	15.10	7.55	2.16	3.24	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	10.96	11.53	3.69	5.54	1.50	0.69
Lens Epithelial Cells, donor3	11690-122I7	11.71	9.18	3.43	3.63	1.01	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	10.91	11.26	4.98	2.85	1.54	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.63	7.54	2.23	0.84	0.56	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	13.69	10.86	6.14	2.05	0.94	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.07	4.84	5.38	1.61	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	6.93	5.04	1.58	0.00	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4.53	3.77	2.16	0.54	0.54	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.18	9.44	4.10	1.64	2.05	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.03	2.78	0.51	0.76	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.36	4.08	1.27	0.99	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.91	13.84	3.96	1.98	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	4.85	7.76	3.10	1.74	0.78	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	1.11	0.74	0.74	0.74	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.01	8.01	3.83	2.09	1.39	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	3.34	5.01	1.91	1.67	0.95	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	3.30	2.75	1.37	0.96	0.69	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.93	12.63	2.77	3.08	1.54	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.36	2.18	0.31	1.56	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	4.03	4.21	1.10	1.65	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	9.22	9.54	3.95	2.30	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.69	2.34	1.46	0.29	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.99	2.49	0.75	0.75	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	16.49	12.12	4.85	0.48	0.97	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.35	8.89	1.62	1.62	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	3.63	2.88	2.72	0.76	0.30	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.29	8.29	3.63	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.75	11.94	3.35	1.88	0.84	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.16	5.56	2.11	0.60	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.69	9.63	4.13	1.38	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.21	6.59	2.26	0.56	0.75	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	3.61	2.23	1.38	0.42	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.02	12.11	3.88	2.91	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	2.65	5.29	4.30	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.48	2.35	1.36	0.62	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	16.29	18.88	6.29	2.59	0.74	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.93	6.18	1.24	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.75	1.51	2.20	0.82	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	16.40	13.83	5.79	1.93	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.22	14.61	3.96	3.04	1.83	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	5.60	7.84	3.50	2.38	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	16.00	17.78	9.24	0.71	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.42	4.85	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	0.78	1.24	0.62	0.31	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	10.74	9.67	5.73	1.79	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	3.92	6.21	1.96	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.06	2.35	0.71	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	18.93	14.85	8.66	1.61	1.36	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.82	4.10	3.07	0.51	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	4.18	2.09	2.69	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	18.13	9.06	2.27	4.53	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.11	5.37	2.30	1.53	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	10.39	6.68	0.74	2.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	13.12	4.23	0.85	0.85	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	12.66	0.70	2.11	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	7.47	5.60	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.82	3.09	2.58	1.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	2.38	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.57	5.65	2.49	1.36	0.90	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	13.67	6.40	3.20	2.91	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.31	7.20	0.90	3.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	17.88	8.81	3.39	2.57	0.95	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	13.35	5.65	3.08	1.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	16.23	6.70	2.12	2.82	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13.99	9.99	1.33	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	16.30	7.64	3.57	3.57	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	17.08	7.20	2.93	2.67	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	18.14	8.12	2.27	3.97	1.51	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	19.63	6.14	2.45	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	17.12	5.71	4.08	3.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	22.49	7.50	2.92	3.33	1.46	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	20.18	8.69	3.08	2.52	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	16.49	8.24	4.12	3.09	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	21.77	10.16	3.77	3.19	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	17.04	5.98	2.99	1.20	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	24.34	9.96	3.32	4.43	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.73	7.78	3.89	1.06	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.97	7.01	2.21	2.58	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	8.06	1.15	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.57	8.44	3.45	1.15	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	16.42	8.49	3.40	2.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	10.67	4.10	2.46	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	16.27	8.59	4.52	1.81	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.83	7.18	3.59	4.31	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.17	8.96	3.73	2.24	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	23.04	6.69	3.34	2.23	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	26.71	6.46	3.45	3.88	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.12	5.99	3.43	0.86	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	27.32	10.66	4.66	4.00	1.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.13	7.24	3.62	2.41	1.81	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	28.44	5.69	2.13	1.42	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	27.15	7.22	4.12	2.75	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	20.40	6.44	2.68	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	22.89	8.75	2.69	2.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.93	8.52	3.70	0.74	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	31.40	4.65	3.49	4.65	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	24.33	7.40	0.00	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	24.41	6.80	2.80	3.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	25.44	7.27	1.45	1.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	20.70	11.50	2.30	2.30	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	15.78	6.91	1.97	1.97	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	19.76	4.70	0.94	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	15.59	6.54	4.02	2.51	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	21.63	6.76	3.60	1.35	1.35	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	6.88	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	25.83	9.35	2.23	2.23	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	18.77	6.26	1.56	3.13	0.78	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	18.47	8.58	4.62	1.32	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	18.16	7.78	1.56	2.08	0.52	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	22.32	8.31	3.50	2.19	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	19.57	11.74	4.47	2.24	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	21.20	7.95	5.30	3.09	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	24.69	8.49	4.63	5.79	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	25.32	8.61	3.04	1.52	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	21.63	9.61	5.29	5.29	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	30.21	11.93	1.19	1.59	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	20.05	7.29	2.43	4.25	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.06	6.23	2.08	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	26.22	11.78	2.66	3.80	1.14	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	26.85	11.36	5.16	1.03	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	21.77	3.02	0.60	2.42	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	19.65	8.56	1.27	3.17	1.27	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	25.06	9.06	4.80	3.73	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	17.24	6.90	1.15	2.87	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	28.80	8.23	2.06	2.06	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.00	8.49	2.83	2.12	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	23.83	8.51	1.70	2.27	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	26.21	6.66	2.91	2.08	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	25.06	5.48	7.05	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.23	8.77	0.42	3.76	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	26.48	8.83	6.04	4.65	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	26.76	9.37	0.00	2.68	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	35.29	6.95	3.21	3.74	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	31.52	9.70	4.45	2.02	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	20.19	11.01	0.92	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	30.23	5.33	0.89	2.67	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	37.04	7.98	4.56	3.99	1.71	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	5.37	3.07	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	22.98	6.57	2.74	1.64	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	24.05	10.25	4.01	3.12	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	30.67	8.84	3.38	1.30	0.78	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	28.51	3.32	5.30	1.33	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	6.24	2.08	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	20.06	14.59	2.51	5.24	0.91	0.23
Macrophage - monocyte derived, donor2	11313-117C8	28.26	20.92	4.95	6.24	1.65	0.18
Macrophage - monocyte derived, donor3	11389-118C3	19.53	15.34	5.24	5.51	0.52	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	18.05	7.97	9.03	2.12	0.53	3.72
Mallassez-derived cells, donor2	11929-125I3	43.89	20.60	13.31	4.75	1.58	2.85
Mallassez-derived cells, donor3	11930-125I4	33.22	19.18	10.98	2.50	0.83	1.53
Mammary Epithelial Cell, donor1	11273-116H4	10.56	12.75	10.26	7.37	0.90	1.30
Mammary Epithelial Cell, donor2	11350-117G9	16.50	11.00	8.11	6.08	0.29	1.74
Mammary Epithelial Cell, donor3	11422-118F9	10.73	4.74	2.00	1.75	0.25	0.50
Mast cell - stimulated, donor1	11487-119E2	237.28	138.98	54.23	10.17	4.75	1.36
Mast cell, donor1	11563-120D6	20.98	13.73	5.41	13.84	1.84	0.32
Mast cell, donor2	11565-120D8	641.00	40.71	40.42	10.10	2.08	0.00
Mast cell, donor3	11566-120D9	296.26	39.62	29.49	13.96	3.38	0.00
Mast cell, donor4	11567-120E1	1023.84	66.13	47.51	8.69	3.01	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	46.91	34.49	13.20	14.64	2.77	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	54.28	25.68	11.67	4.67	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	41.41	20.99	7.92	8.83	2.18	0.23
Mast cell, expanded, donor8	11941-126A6	34.14	16.90	6.69	7.36	1.67	0.17
Melanocyte - dark, donor1	11502-119F8	19.90	18.31	6.67	3.68	1.29	0.50
Melanocyte - dark, donor2	11582-120F7	6.92	7.96	4.15	1.38	0.35	1.38
Melanocyte - dark, donor3	11663-122F7	38.54	70.77	15.79	6.66	3.19	2.54
Melanocyte - light, donor1	11274-116H5	8.70	12.69	4.47	1.65	1.18	0.47
Melanocyte - light, donor2	11351-117H1	7.51	6.82	0.68	1.36	0.00	0.00
Melanocyte - light, donor3	11423-118G1	5.20	8.67	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	29.16	32.59	6.14	6.56	1.56	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	35.23	43.57	11.30	2.42	2.42	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	16.07	19.82	4.29	5.89	1.87	0.54
Meningeal Cells, donor1	11493-119E8	12.78	5.09	1.49	4.34	0.37	0.12
Meningeal Cells, donor2	11573-120E7	7.92	2.64	0.88	3.96	0.00	0.88
Meningeal Cells, donor3	11654-122E7	30.89	16.38	5.30	9.78	1.63	1.39
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	15.40	7.41	3.14	5.13	0.86	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	17.71	15.90	4.73	3.72	0.81	0.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	0.00	1.31	2.63	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	1.31	0.00	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	14.35	10.05	2.15	7.18	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	13.76	10.59	5.72	3.81	1.27	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	17.09	11.56	2.51	3.02	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.47	3.96	2.64	2.42	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	6.58	2.92	0.00	2.19	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.14	3.07	1.64	1.23	0.61	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	7.62	2.63	0.97	3.05	0.14	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1.86	1.12	0.74	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	4.08	2.76	2.37	2.76	0.39	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	1.19	1.48	0.00	0.89	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	3.20	0.64	0.64	1.28	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	30.13	13.82	5.32	7.44	3.54	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	2.50	1.88	3.13	3.44	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.06	9.43	2.90	6.53	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	52.77	27.31	11.67	2.12	1.86	2.39
Mesothelial Cells, donor2	12156-128G5	35.53	16.01	8.01	2.00	1.00	5.51
Mesothelial Cells, donor3	11402-118D7	29.99	12.94	6.72	1.88	0.65	1.16
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	6.75	1.35	2.70	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	18.96	11.82	5.42	5.42	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	19.73	10.89	3.53	7.66	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	10.37	3.46	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	11.16	6.82	3.41	4.03	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.82	7.05	2.70	2.90	0.83	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	2.32	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	13.26	11.26	3.00	4.75	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	19.55	14.43	2.79	2.79	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.23	10.97	3.66	4.88	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	21.38	9.90	2.77	2.77	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	13.27	4.42	2.65	2.65	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	16.72	12.92	4.56	3.04	1.90	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	6.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.64	6.15	2.33	4.03	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	4.60	3.68	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.71	8.35	2.38	2.68	0.89	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	8.38	1.68	1.68	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	12.04	5.27	2.01	2.01	0.25	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	16.16	8.79	2.61	2.38	0.71	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.40	2.21	3.32	1.66	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.28	6.22	0.69	1.84	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.51	9.68	4.21	1.89	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.17	6.32	0.61	1.63	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	7.51	6.22	2.57	1.72	0.64	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.56	4.89	4.89	2.45	1.33	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.20	6.35	2.63	0.88	0.66	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.62	4.06	5.07	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	4.97	1.66	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.52	4.89	1.63	1.90	0.82	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.53	5.59	1.76	1.18	0.59	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	1.09	4.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	7.69	2.40	2.40	0.48	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.01	6.40	2.80	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	2.74	1.37	5.48	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	8.51	6.01	2.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.44	7.01	1.75	1.75	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	5.52	4.41	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	4.48	1.28	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.21	8.18	1.98	3.97	0.99	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.22	4.18	4.87	4.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	4.42	6.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.13	5.13	1.03	1.37	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.94	13.13	2.63	1.31	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	16.33	3.91	2.49	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	11.22	4.49	3.65	2.24	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	30.34	9.56	3.33	2.49	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.24	2.91	2.91	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	7.84	4.83	2.71	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	35.90	12.52	9.60	2.50	0.83	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	13.85	12.01	1.85	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	44.96	10.81	6.26	1.71	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	23.63	6.36	3.73	1.80	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.81	5.96	3.37	1.81	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	45.90	14.16	6.86	1.72	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.07	1.27	3.81	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.28	9.87	2.14	1.87	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	27.54	13.17	6.88	3.89	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.56	5.65	1.98	2.54	0.42	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.01	8.28	1.59	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	34.50	16.14	7.08	1.33	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.89	5.69	3.03	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.63	6.82	2.84	1.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	23.84	11.31	4.92	1.47	0.74	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	6.52	1.96	0.65	1.96	1.96	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.58	4.70	2.65	1.47	0.59	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	20.47	14.13	4.61	3.17	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.95	12.78	5.36	5.36	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.59	8.93	2.68	2.08	0.89	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	5.35	0.00	7.13	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	14.46	7.23	4.27	2.30	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	10.52	6.31	2.10	3.16	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	16.21	13.05	1.78	3.36	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	16.76	12.11	1.86	2.79	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	7.89	7.89	0.75	3.76	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.85	7.99	1.33	4.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.70	10.52	1.70	3.85	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	4.42	2.95	0.74	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	11.73	7.69	1.47	2.93	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	7.78	1.56	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.41	4.81	0.53	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	5.05	0.00	3.03	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.85	5.48	1.26	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1617.99	4.09	38.13	0.00	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	232.07	6.99	8.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	463.23	7.29	10.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	447.09	3.02	12.08	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	4728.02	28.55	137.04	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3239.61	29.36	123.97	6.52	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	494.26	14.26	23.76	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	2296.48	25.10	112.94	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	10.77	9.69	3.88	6.03	0.65	1.72
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	3.66	3.66	0.52	2.61	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	21.36	2.67	2.00	2.00	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.85	3.34	4.17	1.25	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	35.75	15.40	8.37	10.65	1.52	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	47.88	3.19	9.58	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	16.32	3.40	2.04	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	47.78	18.38	9.19	9.19	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.63	3.77	2.93	0.84	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.48	8.37	5.11	2.79	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	9.73	3.51	2.70	1.08	1.35	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	14.09	5.26	3.57	2.10	0.63	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	11.13	22.27	0.00	22.27	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.43	5.46	1.49	0.50	1.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.37	9.74	3.52	3.52	1.35	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.52	5.44	2.27	2.04	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.21	7.02	3.43	2.45	0.98	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.32	6.56	3.10	1.46	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	12.20	3.18	2.12	0.53	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	8.40	5.40	1.20	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	16.08	16.74	4.59	6.56	2.63	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.92	3.58	3.25	2.11	0.65	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	20.81	9.52	5.47	1.41	0.88	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.14	3.52	4.22	0.70	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.19	7.82	2.76	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	15.75	10.60	4.50	2.25	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	11.73	8.97	4.14	7.24	1.72	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	25.28	25.28	12.64	25.28	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.26	9.80	2.45	2.45	1.56	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.70	5.08	2.12	2.12	1.69	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.34	4.03	2.37	0.95	1.19	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	16.31	5.58	0.86	1.72	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	45.14	18.06	18.06	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.33	4.00	2.67	1.33	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	17.13	4.51	1.80	1.80	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.90	3.97	3.97	3.17	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	11.14	1.86	1.86	2.79	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.24	11.35	2.27	4.54	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.80	3.58	0.98	1.96	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.64	2.18	2.18	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	18.09	5.43	3.62	2.26	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.11	7.06	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.96	4.65	0.00	1.33	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.39	3.97	2.48	1.98	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.51	2.68	1.91	0.77	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	14.52	14.52	4.23	6.35	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.38	5.53	1.99	1.11	1.11	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	11.52	2.03	0.00	2.03	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	51.10	20.44	15.33	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.97	2.44	2.44	2.44	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.35	3.78	2.52	1.26	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.32	3.93	1.82	1.21	1.21	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	3.96	4.75	0.00	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	14.74	10.20	5.67	6.80	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	45.52	40.46	0.00	5.06	0.00	5.06
Myoblast, donor1	11241-116D8	12.30	9.81	3.98	3.73	0.87	2.36
Myoblast, donor2	11322-117D8	17.64	13.23	7.29	5.56	1.34	0.77
Myoblast, donor3	11398-118D3	16.14	8.58	2.86	6.89	1.85	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	43.49	20.87	14.16	3.94	0.58	0.00
Natural Killer Cells, donor1	11230-116C6	70.11	45.82	48.28	3.38	3.69	0.00
Natural Killer Cells, donor2	11311-117C6	56.39	36.79	42.22	3.62	4.22	0.00
Natural Killer Cells, donor3	11387-118C1	59.27	25.77	34.05	3.68	3.31	0.00
Neural stem cells, donor1	11275-116H6	18.51	20.69	9.80	6.90	4.36	6.53
Neural stem cells, donor2	11352-117H2	44.29	25.03	7.70	5.78	5.78	0.00
Neurons, donor1	11494-119E9	23.90	38.69	7.97	6.83	3.41	0.00
Neurons, donor2	11574-120E8	20.48	24.66	4.40	8.37	1.98	1.76
Neurons, donor3	11655-122E8	20.55	27.13	9.04	4.11	1.64	0.82
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.61	3.05	1.22	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	4.04	2.85	1.19	2.49	0.47	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	4.23	1.63	0.98	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	6.62	2.01	2.41	2.81	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	1.93	1.93	1.10	2.34	0.28	0.28
Olfactory epithelial cells, donor2	11934-125I8	4.78	2.03	1.30	2.46	0.29	0.29
Olfactory epithelial cells, donor3	11935-125I9	2.95	2.27	2.04	2.61	0.11	1.02
Olfactory epithelial cells, donor4	11936-126A1	4.97	4.58	1.36	2.43	0.29	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	17.45	15.05	6.62	7.82	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	5.74	4.04	2.13	1.91	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	4.57	1.14	1.14	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.97	0.62	1.24	2.48	1.24	0.00
Osteoblast, donor1	11277-116H8	4.50	3.13	1.17	1.17	0.39	0.20
Osteoblast, donor2	11354-117H4	35.82	11.94	6.32	7.73	0.00	2.11
Osteoblast, donor3	11426-118G4	11.73	7.29	1.78	2.67	0.71	0.36
Pancreatic stromal cells, donor1	11249-116E7	16.43	8.09	4.13	5.81	0.76	0.84
Pericytes, donor1	11491-119E6	0.89	0.11	0.33	0.67	0.00	0.00
Pericytes, donor2	11571-120E5	2.04	0.68	0.45	0.45	0.00	0.00
Pericytes, donor3	11652-122E5	2.44	0.20	0.00	1.42	0.00	0.00
Perineurial Cells, donor1	11499-119F5	7.80	3.96	1.36	7.57	0.79	0.79
Perineurial Cells, donor2	11579-120F4	18.86	10.49	5.80	6.16	1.56	0.74
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	15.30	13.39	14.02	5.10	0.96	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	22.04	11.26	15.43	2.20	1.96	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	22.00	18.77	15.66	2.46	2.20	0.00
Placental Epithelial Cells, donor1	11278-116H9	27.50	18.42	6.94	1.67	1.91	0.24
Placental Epithelial Cells, donor2	11355-117H5	8.87	3.33	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.32	1.37	0.79	1.37	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	4.11	1.58	0.95	0.32	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	5.63	7.69	2.81	3.56	0.19	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	17.75	14.36	8.35	7.96	1.04	0.26
Preadipocyte - breast, donor2	11328-117E5	7.43	5.40	2.03	4.73	0.90	0.00
Preadipocyte - omental, donor1	11468-119C1	8.74	8.63	3.20	3.52	0.43	0.43
Preadipocyte - omental, donor2	11329-117E6	7.86	5.24	5.24	3.93	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	6.73	7.16	2.86	6.16	1.00	0.86
Preadipocyte - perirenal, donor1	11469-119C2	7.87	1.97	0.00	2.95	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	7.68	4.30	1.23	2.15	0.92	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	43.56	15.05	9.03	8.85	1.59	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	10.90	9.03	4.43	5.96	2.04	1.87
Preadipocyte - visceral, donor1	11280-116I2	25.06	11.83	7.45	8.66	1.86	1.58
Preadipocyte - visceral, donor2	11357-117H7	23.01	11.04	5.52	2.76	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	18.91	8.05	3.76	4.70	0.10	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	112.08	45.41	22.02	3.77	1.36	0.15
Prostate Epithelial Cells, donor2	11331-117E8	21.80	8.40	6.91	2.44	0.81	1.35
Prostate Epithelial Cells, donor3	11404-118D9	4.84	3.98	1.65	4.16	0.00	0.18
Prostate Stromal Cells, donor1	11254-116F3	16.52	9.00	3.30	4.78	1.48	1.37
Prostate Stromal Cells, donor2	11332-117E9	20.62	6.45	4.66	5.74	0.90	0.54
Prostate Stromal Cells, donor3	11405-118E1	9.59	4.90	2.50	2.61	0.31	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	4.74	1.09	1.09	2.92	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	12.75	10.60	3.47	6.10	0.76	0.49
Renal Epithelial Cells, donor1	11517-119H5	3.55	3.04	1.52	1.52	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	2.13	1.42	2.85	0.00	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	13.13	12.17	4.76	6.35	1.48	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	1.36	0.68	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.62	3.23	1.75	0.81	0.13	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	32.19	13.99	5.33	3.77	0.89	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	3.99	1.33	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.06	2.86	2.42	1.10	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.76	2.51	1.88	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	1.94	1.11	0.83	1.11	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	13.15	6.44	1.34	1.88	0.27	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.33	3.80	0.42	2.95	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	5.21	2.51	1.74	2.12	0.19	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	26.71	16.08	5.44	4.41	1.81	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.39	3.41	1.99	1.42	0.28	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	1.03	1.03	2.06	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	11.79	5.02	3.01	4.01	0.25	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	951.89	65.35	46.51	3.47	2.54	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	12.51	5.36	2.68	5.36	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	16.51	19.26	3.85	10.46	4.95	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.02	15.08	1.16	5.22	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	36.80	23.66	4.55	20.41	1.04	3.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	27.11	19.56	4.27	14.60	1.49	2.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	30.45	31.45	6.47	16.84	4.35	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	47.76	35.72	7.44	30.27	3.10	3.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	35.55	22.96	5.83	17.25	2.21	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	49.69	25.66	5.32	15.95	3.70	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	34.09	19.85	3.01	10.95	1.92	2.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	39.48	20.88	4.99	15.28	2.42	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	39.24	37.45	9.50	16.31	3.76	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	25.97	19.94	2.87	13.77	0.72	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	34.02	21.78	3.76	14.38	2.79	2.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	32.53	22.57	6.20	15.71	2.66	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	34.22	22.75	3.44	12.62	1.72	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	31.30	21.61	5.31	14.72	2.52	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	43.03	37.02	7.14	22.92	6.20	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	32.78	17.38	4.25	12.87	0.93	1.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	28.91	19.86	4.87	14.70	2.92	1.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	27.31	27.88	4.01	18.33	3.63	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	24.35	19.44	5.34	15.70	0.85	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	29.15	17.94	3.92	13.73	2.80	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	30.76	28.88	5.98	14.70	3.42	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	25.53	19.87	3.28	11.49	2.37	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.42	18.03	4.05	12.75	1.47	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	28.07	24.31	4.43	15.04	2.82	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	29.25	20.52	3.54	12.74	1.65	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	24.01	18.25	3.17	15.48	2.18	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	34.61	22.45	2.57	16.37	3.27	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	33.59	23.43	4.56	14.51	3.53	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	23.23	17.25	3.32	12.61	1.55	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	33.42	23.60	5.43	15.25	2.92	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	39.70	25.17	5.11	14.94	2.02	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	17.03	19.24	3.92	14.13	2.21	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	43.38	26.80	7.52	17.16	4.82	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	51.75	28.89	6.02	13.76	1.72	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	27.98	19.34	5.08	17.69	2.06	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	51.88	29.22	7.72	19.70	5.25	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	30.34	20.96	2.73	12.61	1.36	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	20.71	20.57	3.55	17.46	2.96	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	32.25	30.65	8.53	15.99	3.73	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	15.76	9.82	1.52	11.48	0.83	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	23.57	22.86	4.76	17.62	2.62	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	37.69	35.07	4.03	15.12	3.83	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	11.77	9.79	1.70	9.23	1.04	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	21.66	14.67	4.54	13.63	1.05	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	7.86	11.18	2.12	8.16	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.34	13.95	3.18	10.89	0.73	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	16.59	12.81	3.49	12.81	2.62	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	15.21	12.78	3.65	12.78	2.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	19.89	16.28	5.43	9.04	1.51	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	23.30	16.74	4.07	12.89	2.04	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	13.48	12.28	4.49	10.48	1.50	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	32.35	15.70	4.13	14.64	1.42	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	16.86	11.53	3.42	8.11	1.49	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	16.83	7.81	3.00	6.61	3.00	0.00
Schwann Cells, donor1	11498-119F4	4.89	1.32	0.38	1.32	0.00	0.19
Schwann Cells, donor2	11578-120F3	10.21	6.80	3.40	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	17.53	5.70	1.75	4.38	1.31	1.10
Sebocyte, donor1	11220-116B5	16.98	11.50	2.74	3.83	0.55	0.00
Sebocyte, donor2	11301-117B5	7.81	5.97	3.22	2.30	0.46	0.46
Sebocyte, donor3	11378-118B1	3.50	3.30	1.65	0.41	0.41	0.21
Sertoli Cells, donor1	11255-116F4	11.60	4.97	0.00	8.28	0.00	1.66
Sertoli Cells, donor2	11333-117F1	0.00	5.65	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	8.27	3.70	2.11	6.95	0.97	0.88
Skeletal Muscle Cells, donor2	11358-117H8	5.06	1.45	0.72	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	16.72	2.51	0.00	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	21.68	8.64	2.98	8.95	0.63	0.94
Skeletal Muscle Cells, donor5	11455-119A6	15.16	7.73	3.12	6.69	0.59	0.59
Skeletal Muscle Cells, donor6	11459-119B1	33.55	13.54	4.16	9.23	1.08	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	7.56	2.90	1.51	5.42	0.76	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	9.13	4.28	1.71	4.00	0.43	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	36.01	14.98	5.06	9.92	1.69	1.39
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	12.39	8.17	2.86	6.66	0.42	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	2.17	2.17	0.72	1.45	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.74	3.30	1.10	1.51	0.28	0.14
Skin - palm, donor1	10286-104F7	18.80	8.06	8.06	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.11	5.19	1.59	1.44	0.43	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	34.35	20.45	5.73	3.27	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.15	5.45	3.76	0.78	0.13	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	9.45	4.45	6.26	4.31	0.28	1.53
Small Airway Epithelial Cells, donor2	11334-117F2	4.36	3.66	4.22	2.11	0.00	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	52.44	25.16	19.24	9.94	2.11	1.90
Small Airway Epithelial Cells, donor3	11406-118E2	8.84	4.57	5.47	3.30	0.22	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	6.17	2.47	0.31	0.00	0.00	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	15.34	8.89	3.33	4.45	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	11.76	4.70	4.70	1.18	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	14.81	6.41	3.09	3.09	0.44	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	18.51	8.27	4.33	1.97	0.00	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	12.36	7.73	4.64	0.00	0.77	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	4.00	1.00	0.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	15.17	5.06	5.32	3.33	0.93	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	5.76	5.98	2.66	3.10	0.89	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.19	6.02	3.20	3.97	0.13	2.82
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	7.16	4.23	3.58	3.26	2.28	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	13.88	9.75	5.32	8.86	0.59	1.48
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.82	5.41	3.13	2.85	0.28	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.63	0.98	0.65	0.65	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	2.44	1.83	0.61	1.22	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	7.07	2.78	3.28	2.27	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	0.95	0.00	0.48	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.98	9.73	4.13	3.24	0.74	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	11.19	6.46	2.80	3.23	0.43	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	17.63	8.82	2.31	5.04	1.15	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	13.15	8.97	5.26	1.55	1.24	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	7.55	2.16	1.08	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	22.41	8.67	6.87	2.39	0.60	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.83	1.71	1.02	1.37	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	8.48	5.65	2.67	3.30	0.39	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	10.87	9.96	3.52	3.62	1.41	1.31
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	25.03	16.16	10.47	1.59	1.37	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	5.43	4.23	0.00	0.60	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	70.21	23.05	10.60	14.04	3.97	2.12
Smooth Muscle Cells - Prostate, donor1	11257-116F6	16.91	6.66	4.39	6.26	0.53	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	9.77	5.01	2.13	3.13	0.50	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	2.79	2.54	1.01	2.28	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	26.54	14.47	9.50	4.67	1.66	1.21
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.00	1.50	1.50	3.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	6.46	2.58	2.58	7.75	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.05	2.33	4.19	1.86	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.16	4.54	5.05	1.01	0.00	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.36	5.64	5.95	1.57	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.47	0.29	0.00	0.29	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	32.49	12.16	4.50	11.91	1.75	0.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.41	1.40	0.93	4.20	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.75	3.89	2.01	1.30	0.29	0.86
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.24	4.33	3.06	3.82	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	7.33	0.94	0.94	1.88	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	18.03	8.38	4.19	9.36	0.84	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	4.27	2.60	1.09	5.03	0.34	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	0.48	0.00	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	5.38	3.91	0.73	1.96	0.24	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	37.56	15.69	10.38	5.30	0.44	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.97	3.51	1.76	3.80	0.88	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	5.25	7.00	1.36	1.94	0.78	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.99	4.76	3.17	1.59	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.30	8.55	2.23	2.23	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	11.86	8.62	1.80	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	21.01	9.94	6.81	2.56	1.14	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	20.09	9.45	5.12	3.94	0.39	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	5.84	3.81	1.78	2.29	0.51	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	3.99	3.59	0.80	1.20	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	9.61	4.60	0.84	2.93	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	7.33	3.21	1.83	0.92	0.46	0.00
Synoviocyte, donor1	11291-117A4	18.18	16.33	6.73	3.53	1.51	0.34
Synoviocyte, donor2	11368-117I9	3.86	3.35	1.01	2.01	0.50	0.00
Synoviocyte, donor3	11440-118H9	6.26	2.90	0.89	2.68	0.22	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	6.07	5.36	1.07	1.07	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	2.78	0.93	0.93	1.16	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	7.81	4.80	3.23	2.22	0.50	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	2.71	1.93	1.55	1.16	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	2.86	1.15	2.29	0.57	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	974.47	67.54	39.37	4.92	3.69	0.86
Urethra, donor2	10319-105A4	8.99	25.18	10.79	1.80	3.60	0.00
Urothelial Cells, donor1	11520-119H8	2.13	2.92	0.27	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.20	1.60	0.80	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	1.15	1.15	0.92	0.69	0.46	0.00
Urothelial cells, donor0	11216-116B1	11.37	8.69	6.24	7.13	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	10.68	6.23	0.89	3.56	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	14.30	4.29	1.43	10.01	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	5.48	4.11	2.74	1.37	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	9.99	5.51	5.85	4.48	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	4.07	9.30	2.91	3.49	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	9.37	5.21	1.04	5.21	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	11.01	5.51	4.59	7.34	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	6.39	5.48	2.74	4.56	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	25.91	11.23	4.32	7.53	0.62	1.97
Wilms' tumor cell line:HFWT	10597-108E3	8.80	0.00	2.64	6.16	0.88	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	23.18	15.64	6.98	9.22	1.12	1.12
achilles tendon, donor2	10292-104G4	22.73	8.27	6.20	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	113.46	42.58	21.93	13.26	1.78	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	35.99	22.29	12.54	12.77	1.16	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	43.92	28.25	8.31	9.38	2.26	0.83
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	125.44	48.98	20.41	9.52	4.08	4.35
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	85.45	32.04	7.31	8.99	3.37	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	12.90	12.27	2.11	9.73	2.54	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	28.85	15.24	6.26	4.90	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	30.40	7.93	4.41	1.76	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	21.23	25.32	2.86	13.48	4.08	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	40.38	30.68	5.44	7.77	1.55	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	54.10	26.31	9.75	20.98	1.47	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	3.90	0.00	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	91.09	28.35	12.32	9.06	2.56	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	60.58	24.08	6.99	13.46	2.59	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	53.48	15.49	4.38	8.18	1.17	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	38.58	14.87	4.18	6.04	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	24.26	35.78	6.17	16.45	1.23	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	49.42	19.03	9.21	2.46	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	76.81	32.86	14.51	6.83	2.13	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	65.51	32.15	10.01	12.13	3.03	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	76.30	35.62	15.41	6.98	2.17	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	57.02	22.27	7.35	6.68	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	55.70	18.68	4.00	8.01	1.67	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	27.87	9.29	13.01	5.57	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	48.21	12.81	9.79	3.77	2.26	2.64
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	18.75	6.98	2.62	3.49	1.31	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	9.37	1.87	3.75	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	6.12	2.83	2.12	0.94	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	22.49	14.27	6.20	6.83	1.09	0.00
adipose, donor1	10184-103D4	35.18	17.01	9.38	16.42	1.17	1.17
adipose, donor2	10185-103D5	9.33	5.68	2.84	1.22	0.41	0.00
adipose, donor3	10186-103D6	18.52	10.35	4.36	6.53	0.54	0.82
adipose, donor4	10187-103D7	20.80	12.13	3.47	9.53	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	29.67	13.41	4.58	5.52	0.79	0.95
adrenal gland, adult, pool1	10081-102A9	25.46	14.55	0.00	7.28	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	12.27	13.21	7.20	6.54	0.93	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	35.02	24.65	14.29	4.29	1.79	1.79
amniotic membrane cells, donor1	12235-129G3	62.83	49.62	14.84	8.58	1.16	0.93
amniotic membrane cells, donor2	12236-129G4	15.21	10.48	5.41	5.07	1.69	0.34
amniotic membrane cells, donor3	12237-129G5	33.29	42.42	15.02	5.60	1.47	0.00
amygdala - adult, donor10196	10167-103B5	86.56	87.75	23.72	9.49	1.19	5.93
amygdala, adult, donor10252	10151-102I7	94.08	106.25	23.32	9.33	5.68	2.03
amygdala, newborn, donor10223	10360-105E9	905.37	57.13	25.18	5.81	4.84	3.87
anaplastic carcinoma cell line:8305C	10428-106D5	19.86	10.44	9.80	1.27	0.13	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	27.80	13.24	5.29	5.29	1.54	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	29.73	33.07	17.37	7.01	2.00	1.00
aorta, adult, pool1	10052-101G7	104.15	14.71	5.49	1.57	0.39	0.00
appendix, adult	10189-103D9	49.68	20.57	15.52	4.66	2.33	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	50.56	32.33	16.85	9.97	2.41	2.75
artery, adult	10190-103E1	21.74	17.66	1.36	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	16.66	5.36	3.77	5.79	0.58	0.58
b cell line:RPMI1788	10427-106D4	69.15	11.60	17.40	5.35	1.49	1.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	6.38	4.99	2.77	3.61	0.55	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	10.62	5.06	3.87	5.95	0.40	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	3.35	1.84	1.67	7.70	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	7.27	6.71	2.80	3.91	0.56	0.00
bladder, adult, pool1	10011-101C2	53.02	19.12	6.19	6.74	1.09	0.00
blood, adult, pool1	10053-101G8	2.21	2.21	0.00	4.43	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	2.57	2.57	2.57	0.86	0.00	0.00
bone marrow, adult	10192-103E3	39.81	10.12	2.70	4.72	0.00	0.00
brain, adult, donor1	10084-102B3	28.70	25.63	5.13	1.03	1.03	0.00
brain, adult, pool1	10012-101C3	42.32	49.78	19.71	7.68	3.56	2.23
brain, fetal, pool1	10085-102B4	58.77	29.39	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	26.43	10.57	7.93	5.62	0.99	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	47.68	27.59	16.10	8.74	2.75	0.50
breast, adult, donor1	10080-102A8	136.37	22.73	10.10	4.42	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	45.61	8.89	5.46	9.78	0.38	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	11.44	8.35	3.09	3.40	1.24	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	7.83	4.14	5.06	3.91	0.23	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	7.02	2.42	1.94	3.39	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	15.52	13.63	2.82	18.34	1.88	1.88
carcinoid cell line:NCI-H727	10735-110B6	12.47	5.36	3.28	4.27	0.44	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	17.43	10.14	3.80	3.17	0.00	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	22.63	14.64	6.65	13.04	0.53	1.33
caudate nucleus - adult, donor10196	10177-103C6	97.86	87.50	28.78	3.45	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	153.77	124.49	57.73	8.20	6.53	3.85
caudate nucleus, adult, donor10258	10379-105H1	93.99	81.00	40.50	3.82	2.29	6.88
caudate nucleus, newborn, donor10223	10354-105E3	884.09	100.35	62.99	4.03	3.66	3.66
cerebellum - adult, donor10196	10173-103C2	26.22	37.87	2.91	2.91	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	49.11	58.72	8.75	12.60	3.42	1.71
cerebellum, adult, pool1	10083-102B2	12.42	7.59	1.38	4.14	0.34	1.03
cerebellum, newborn, donor10223	10357-105E6	195.12	16.61	6.64	2.49	2.49	1.66
cerebral meninges, adult	10188-103D8	105.39	54.46	12.86	10.34	1.26	0.76
cerebrospinal fluid, donor2	10294-104G6	18.27	12.43	5.12	3.65	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	3.31	1.87	2.30	4.03	0.43	0.14
cervical cancer cell line:ME-180	10553-107I4	28.17	16.74	17.90	5.14	1.49	0.17
cervix, adult, pool1	10013-101C4	22.15	12.07	3.78	5.35	1.36	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	48.35	35.67	12.40	4.88	1.95	1.67
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	2.61	3.92	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	31.94	8.70	4.97	7.21	0.99	0.25
choriocarcinoma cell line:SCH	10785-110H2	14.54	7.52	2.22	9.24	0.86	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	71.86	7.59	4.03	4.51	1.19	0.24
chorionic membrane cells, donor1	12238-129G6	41.03	23.36	12.82	3.42	1.71	0.28
chorionic membrane cells, donor2	12239-129G7	30.53	19.69	12.13	6.76	1.69	0.70
chorionic membrane cells, donor3	12240-129G8	31.32	12.64	8.24	4.40	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	38.37	16.16	6.06	4.04	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	47.45	21.52	5.38	6.92	1.92	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	41.60	12.25	9.50	7.60	0.63	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	30.05	8.47	10.02	3.34	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	31.20	9.19	7.26	5.32	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	28.91	11.81	8.14	3.87	0.20	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	65.37	17.96	22.67	3.53	0.88	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	43.52	16.42	6.78	16.42	4.95	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	20.57	17.37	3.43	5.49	0.91	0.00
clear cell carcinoma cell line:TEN	10636-108I6	30.88	14.05	7.11	3.99	1.04	0.17
colon carcinoma cell line:CACO-2	10513-107D9	51.43	24.53	20.68	4.76	0.55	0.00
colon carcinoma cell line:COLO-320	10420-106C6	22.80	11.78	5.70	17.86	2.28	0.76
colon, adult, donor1	10082-102B1	17.85	7.14	3.57	3.57	0.00	0.00
colon, adult, pool1	10014-101C5	23.03	7.99	3.06	6.58	0.71	0.00
colon, fetal, donor1	10070-101I7	14.83	1.85	0.62	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	68.75	27.50	32.08	9.17	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	186.97	50.14	69.69	4.67	2.97	4.25
cord blood derived cell line:COBL-a 24h infection	10453-106G3	72.75	31.54	31.54	7.09	1.96	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	76.85	38.64	29.75	8.32	1.83	1.83
corpus callosum, adult, pool1	10042-101F6	51.96	30.85	3.21	6.19	1.44	0.66
cruciate ligament, donor2	10295-104G7	11.35	6.48	0.00	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	16.85	8.83	4.01	2.41	1.61	0.00
diencephalon, adult	10193-103E4	55.20	48.24	14.16	6.24	3.60	3.12
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	37.20	10.79	9.87	8.95	1.61	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	21.03	10.00	11.03	6.15	0.51	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	45.50	13.96	14.92	2.89	2.41	0.24
ductus deferens, adult	10196-103E7	46.84	24.92	12.96	5.48	3.99	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	21.60	5.76	2.88	5.76	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	20.60	11.77	3.68	5.15	0.00	0.74
dura mater, adult, donor1	10041-101F5	7.19	5.78	3.06	5.62	0.74	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	30.42	42.86	15.32	3.33	1.11	2.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	31.38	18.77	8.02	5.45	2.72	2.29
embryonic pancreas cell line:1B2C6	10604-108F1	42.55	12.33	19.12	3.08	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	45.71	15.14	16.95	3.33	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	38.59	13.28	10.19	8.34	0.00	1.54
embryonic pancreas cell line:2C6	10603-108E9	59.11	15.76	14.45	5.25	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	15.42	4.36	3.35	3.69	0.34	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	14.32	9.79	3.08	5.07	0.91	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	11.90	8.84	2.09	2.41	0.32	0.48
epidermoid carcinoma cell line:A431	10426-106D3	22.68	13.34	9.89	2.22	0.89	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	54.88	20.79	13.09	2.31	0.99	0.99
epididymis, adult	10197-103E8	17.16	11.09	4.40	7.12	1.26	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	9.58	10.11	2.31	2.66	0.53	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	42.08	11.80	5.90	0.39	0.39	2.75
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	61.86	33.68	15.46	2.88	1.44	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	18.70	7.78	5.61	4.43	0.39	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	52.32	27.34	14.34	2.69	1.23	0.56
esophagus, adult, pool1	10015-101C6	29.52	11.79	4.99	5.52	0.53	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	33.06	9.52	5.51	11.65	1.50	1.13
eye - muscle inferior rectus, donor1	10272-104E2	7.24	9.66	4.83	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	6.31	16.83	4.21	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	5.95	10.42	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	9.17	10.32	1.15	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	17.49	11.66	2.91	4.37	0.00	0.00
eye, fetal, donor1	10054-101G9	9.66	11.19	2.03	4.07	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	12.18	5.26	1.67	8.46	0.77	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	51.76	18.99	10.21	4.75	0.95	0.95
frontal lobe, adult, pool1	10040-101F4	67.18	80.41	32.56	12.67	4.88	3.85
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	23.72	12.91	5.10	10.81	2.40	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	19.93	20.12	5.94	8.05	0.46	0.46
gall bladder, adult	10198-103E9	11.11	5.79	3.14	3.62	0.97	0.00
gamma delta positive T cells, donor1	11937-126A2	8.05	9.13	5.91	14.50	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	9.71	5.60	4.48	3.36	1.49	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	37.60	16.26	13.52	6.34	0.42	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	30.95	14.12	7.35	19.15	1.35	0.77
gastric cancer cell line:AZ521	10549-107H9	15.08	13.61	10.33	13.77	1.48	3.77
gastric cancer cell line:GSS	10560-108A2	52.17	10.07	4.58	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	60.77	21.93	10.28	11.65	0.91	0.23
giant cell carcinoma cell line:LU65	10487-107B1	8.84	6.20	2.29	6.65	0.46	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	98.81	10.78	14.00	4.76	0.84	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	37.91	19.21	5.74	1.00	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	14.67	11.93	3.69	2.53	0.84	2.01
glioblastoma cell line:A172, tech_rep2	10444-106F3	16.57	13.20	4.92	2.67	0.56	1.97
glioblastoma cell line:T98G	10485-107A8	21.08	8.72	11.59	4.86	0.44	1.21
glioma cell line:GI-1	10413-106B8	29.58	16.11	5.27	8.49	0.88	0.29
globus pallidus - adult, donor10196	10175-103C4	40.09	48.84	13.85	4.37	1.46	0.73
globus pallidus, adult, donor10252	10161-103A8	102.76	130.83	15.13	11.47	7.08	0.24
globus pallidus, adult, donor10258	10367-105F7	20.54	26.01	2.74	2.74	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	272.32	42.63	30.38	3.20	3.20	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	75.86	22.02	26.92	17.13	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	10.93	10.93	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	13.44	6.40	3.20	3.84	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	24.79	11.48	6.43	3.67	0.46	1.84
hIPS +CCl2, biol_rep2	14384-156C1	27.44	15.55	3.20	2.29	0.46	2.29
hIPS +CCl2, biol_rep3	14385-156C2	25.12	16.10	1.93	10.31	0.64	1.93
hIPS, biol_rep1	14380-156B6	24.43	20.12	5.75	4.31	0.00	0.00
hIPS, biol_rep2	14381-156B7	24.69	13.72	6.17	2.74	0.00	1.37
hIPS, biol_rep3	14382-156B8	83.86	40.83	17.66	3.31	1.10	3.31
hairy cell leukemia cell line:Mo	10712-109I1	31.61	19.54	9.48	7.47	0.86	0.29
heart - mitral valve, adult	10205-103F7	160.84	34.08	10.76	2.99	1.49	0.60
heart - pulmonic valve, adult	10206-103F8	14.64	13.07	2.61	5.75	0.78	0.26
heart - tricuspid valve, adult	10207-103F9	335.55	62.45	18.32	5.83	1.67	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	4.69	5.31	0.82	3.67	0.82	0.00
heart, adult, diseased, donor1	10051-101G6	2.98	4.26	0.00	2.98	0.00	0.00
heart, adult, pool1	10016-101C7	25.30	22.77	4.83	3.68	0.46	0.00
heart, fetal, pool1	10046-101G1	51.34	33.17	7.80	7.50	1.13	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	10.80	7.40	4.32	2.47	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	103.46	13.08	14.27	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	45.97	30.50	15.69	5.86	2.54	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	60.08	33.98	12.87	5.34	1.58	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	51.74	30.01	13.34	8.19	4.45	0.61
hepatoma cell line:Li-7	10484-107A7	12.34	8.01	5.34	5.56	0.56	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	61.61	28.84	14.17	16.38	2.01	1.61
hippocampus - adult, donor10196	10169-103B7	62.46	63.40	6.62	5.68	9.46	0.95
hippocampus, adult, donor10252	10153-102I9	84.70	101.44	19.39	10.20	6.53	1.63
hippocampus, adult, donor10258	10374-105G5	69.71	65.73	13.94	3.49	1.00	1.00
hippocampus, newborn, donor10223	10363-105F3	342.26	39.48	26.08	3.52	2.47	4.23
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	46.39	34.18	9.77	9.16	4.88	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	32.79	17.28	4.12	7.85	1.57	1.96
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	26.91	17.26	3.05	9.39	0.76	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	10.71	16.35	1.69	4.51	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	17.56	13.69	3.61	5.42	0.52	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	19.74	15.94	3.42	6.83	2.66	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	19.27	10.51	7.01	5.84	1.17	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	28.65	8.83	3.45	4.95	1.08	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	38.79	14.18	4.59	5.00	1.67	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	23.21	12.55	6.87	3.79	1.66	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	18.00	12.86	4.34	5.79	1.61	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.20	12.79	5.39	8.75	0.67	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	27.54	18.78	2.97	6.73	0.78	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	31.44	16.21	3.93	6.88	0.98	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.06	25.31	6.11	8.73	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	21.38	18.71	4.58	5.15	1.53	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	24.42	12.21	5.67	4.36	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	21.99	18.99	4.50	6.00	2.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	13.00	6.03	1.70	2.83	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	13.64	5.00	0.91	3.18	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	12.22	4.07	1.88	2.82	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	13.06	9.96	3.10	3.76	1.14	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	19.16	9.00	2.90	2.32	0.00	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.96	7.17	2.69	2.09	1.49	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	29.19	15.52	4.43	8.87	1.11	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	27.67	18.54	3.99	7.99	2.00	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	35.11	26.13	6.12	10.21	2.04	4.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	16.20	9.86	1.76	5.28	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	15.84	12.99	1.90	7.92	0.63	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	18.46	11.20	3.93	4.24	2.72	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.20	8.79	2.07	5.69	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	14.61	5.98	4.65	1.33	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	16.42	6.93	2.82	2.05	1.03	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	29.91	14.57	3.58	3.07	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	22.72	9.09	2.27	3.79	3.03	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	20.50	12.10	3.02	3.36	2.35	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	25.60	16.91	3.38	8.45	1.21	2.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.50	16.04	3.57	7.13	1.34	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	22.44	25.37	3.41	7.80	0.98	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	22.62	11.31	2.44	4.58	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	71.57	74.82	16.27	61.81	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	13.24	19.86	2.32	7.28	2.65	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	19.70	9.30	2.19	4.38	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.48	6.15	1.45	3.26	0.72	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	19.22	11.03	1.42	2.85	0.36	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	20.29	4.77	4.77	4.77	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	34.26	19.91	4.47	8.67	1.63	2.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	19.67	13.47	4.31	2.42	1.08	0.54
immature langerhans cells, donor1	11904-125F5	107.51	20.82	21.79	2.18	0.48	0.24
immature langerhans cells, donor2	11905-125F6	160.80	19.80	26.93	2.38	0.79	0.00
insula, adult, pool1	10039-101F3	64.45	74.19	26.78	10.79	6.15	3.31
keratoacanthoma cell line:HKA-1	10791-110H8	46.82	21.46	13.01	4.55	0.98	0.33
kidney, adult, pool1	10017-101C8	27.84	20.83	6.61	5.11	1.50	0.60
kidney, fetal, pool1	10045-101F9	122.16	16.06	5.45	4.46	0.85	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	29.82	15.91	6.96	4.83	0.99	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.44	4.42	2.07	1.66	0.14	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	19.63	9.73	6.61	2.94	0.00	0.37
left atrium, adult, donor1	10079-102A7	2.72	1.09	0.00	2.18	0.00	0.00
left ventricle, adult, donor1	10078-102A6	4.05	6.07	0.51	2.53	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	15.60	5.75	2.19	5.20	1.37	1.64
leiomyoma cell line:10964C	10569-108B2	12.57	5.03	3.59	1.44	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	19.02	5.43	1.09	1.63	0.00	0.00
leiomyoma cell line:15425	10571-108B4	22.82	4.86	4.37	3.89	0.00	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	13.59	14.64	11.50	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	47.70	20.07	16.41	3.54	1.30	0.12
liposarcoma cell line:KMLS-1	10782-110G8	21.24	7.97	5.94	3.59	0.00	0.31
liposarcoma cell line:SW 872	10726-110A6	11.57	5.60	6.94	2.92	0.24	0.73
liver, adult, pool1	10018-101C9	8.91	4.54	1.62	6.00	0.97	0.00
liver, fetal, pool1	10086-102B5	100.66	8.47	5.64	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	52.06	28.73	7.29	3.79	0.87	1.02
locus coeruleus, adult, donor10252	10165-103B3	132.32	103.35	13.66	8.86	6.09	0.92
locus coeruleus, adult, donor10258	10375-105G6	55.86	16.65	4.51	2.54	2.82	1.13
locus coeruleus, newborn, donor10223	10362-105F2	272.98	57.20	14.30	5.89	2.10	2.52
lung adenocarcinoma cell line:A549	10499-107C4	13.56	3.88	4.43	3.88	0.42	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	22.75	8.27	6.89	2.07	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	2.77	1.45	0.13	2.64	0.13	0.00
lung, adult, pool1	10019-101D1	97.69	20.67	5.79	5.55	1.54	0.24
lung, fetal, donor1	10068-101I5	161.26	54.23	10.85	10.27	2.00	0.57
lung, right lower lobe, adult, donor1	10075-102A3	46.74	19.25	3.67	5.96	0.46	0.46
lymph node, adult, donor1	10077-102A5	7.57	2.37	2.37	0.95	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	7.89	5.26	2.19	5.26	0.22	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	79.09	36.83	20.07	8.90	2.41	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.09	22.94	4.25	3.40	1.70	0.00
mature adipocyte, donor1	12231-129F8	190.03	18.65	7.55	4.88	0.44	0.00
mature adipocyte, donor2	12232-129F9	171.00	15.98	6.02	4.15	0.21	0.21
mature adipocyte, donor3	12233-129G1	64.24	15.65	4.03	2.61	0.24	0.00
mature adipocyte, donor4	12234-129G2	144.24	16.58	6.84	2.63	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	26.69	15.73	5.96	13.34	1.91	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	109.42	107.16	30.46	6.77	2.26	5.64
medial frontal gyrus, adult, donor10252	10150-102I6	76.69	109.42	24.46	7.36	5.52	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	46.70	53.37	15.88	3.49	1.59	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	606.89	128.37	49.47	8.53	9.38	8.53
medial temporal gyrus - adult, donor10196	10183-103D3	70.20	78.81	22.95	9.45	4.89	2.87
medial temporal gyrus, adult, donor10252	10156-103A3	79.80	119.69	19.74	7.85	5.09	2.76
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	100.17	5.78	5.78	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	186.60	244.01	100.48	57.41	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	572.14	82.20	37.69	6.82	5.38	6.10
medulla oblongata - adult, donor10196	10174-103C3	59.06	38.29	5.84	3.89	1.95	1.95
medulla oblongata, adult, donor10252	10155-103A2	197.53	104.18	17.96	9.44	5.88	0.62
medulla oblongata, adult, pool1	10038-101F2	53.06	21.71	5.71	5.06	0.98	0.49
medulla oblongata, newborn, donor10223	10361-105F1	195.12	50.69	10.07	2.08	3.12	1.39
medulloblastoma cell line:D283 Med	10838-111E1	36.75	7.09	2.44	8.64	1.11	0.66
medulloblastoma cell line:ONS-76	10759-110E3	76.67	20.54	10.52	3.55	2.20	2.20
melanoma cell line:COLO 679	10514-107E1	12.79	9.63	4.17	13.66	1.72	1.01
melanoma cell line:G-361	10465-106H6	27.69	11.13	8.96	8.96	1.36	1.09
meningioma cell line:HKBMM	10691-109F7	53.01	16.10	10.49	2.35	0.36	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	55.51	44.94	9.69	8.81	1.76	7.93
merkel cell carcinoma cell line:MS-1	10844-111E7	65.84	58.84	12.96	23.85	6.74	6.48
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.02	10.13	5.68	5.22	0.31	1.69
mesenchymal precursor cell - adipose, donor2	11748-123G2	8.00	3.64	2.91	3.09	0.55	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	13.67	4.56	4.14	5.80	0.00	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	32.03	13.20	8.43	4.07	0.56	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.29	9.05	5.97	3.47	0.58	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.94	3.47	0.00	2.08	1.39	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	13.04	7.55	3.26	4.63	1.03	1.89
mesenchymal precursor cell - cardiac, donor2	11753-123G7	15.41	7.94	3.45	3.57	0.23	1.38
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.31	7.43	5.44	2.79	0.13	1.33
mesenchymal precursor cell - cardiac, donor4	11755-123G9	47.26	22.15	12.56	3.65	0.95	1.22
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	37.56	12.38	10.67	4.84	0.71	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	19.76	9.55	3.62	2.96	1.32	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	14.94	8.30	5.67	4.57	0.42	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	24.78	9.77	6.98	3.49	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	12.45	6.74	2.04	4.49	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	10.78	11.14	4.31	1.80	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	9.31	5.38	1.97	2.07	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	13.91	8.44	6.16	0.68	0.46	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	56.22	17.20	13.43	5.45	0.42	4.20
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	14.79	7.02	4.48	4.93	0.45	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	22.58	7.79	7.53	3.85	0.35	1.40
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	18.04	11.78	3.68	3.68	0.00	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	9.16	8.58	5.44	4.29	0.57	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	18.95	10.10	4.63	3.79	1.26	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	7.76	1.37	1.37	2.74	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	6.14	3.33	0.77	2.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	8.11	2.36	1.57	3.93	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	5.24	3.08	0.92	2.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	6.12	2.35	2.82	2.12	0.24	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	5.75	1.02	1.35	1.69	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	7.86	1.96	0.39	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.41	2.78	1.85	1.85	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	4.90	3.46	1.73	3.75	0.00	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	5.35	2.45	0.89	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	5.05	2.16	0.96	1.68	0.24	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	8.80	2.93	2.20	2.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	6.71	1.34	1.68	0.67	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	7.37	2.46	2.46	1.23	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	7.73	3.44	1.29	1.72	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.82	3.90	1.95	2.60	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	4.36	7.27	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.60	6.93	2.13	2.13	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	7.36	0.82	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	6.61	2.72	2.33	1.55	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	4.20	0.00	6.30	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5.96	0.99	0.99	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.93	2.96	0.59	1.19	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	0.00	1.22	2.44	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	3.80	6.33	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	5.52	3.45	1.38	1.03	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	0.00	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.11	1.63	2.85	3.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	3.97	2.38	1.59	2.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	4.72	5.90	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	6.55	5.92	1.56	3.74	1.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	5.35	6.68	0.00	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	4.73	1.18	2.37	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	7.70	0.00	2.57	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	12.39	7.57	2.07	4.82	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	12.37	4.45	2.97	2.97	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	6.73	2.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	2.54	0.64	4.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.04	2.42	0.40	0.81	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	0.00	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	3.64	1.21	0.00	1.82	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	4.94	1.65	0.82	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.54	5.16	1.39	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	5.52	4.87	0.97	0.65	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	2.04	4.07	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	3.09	4.64	3.87	3.87	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	35.20	8.74	15.36	7.32	0.71	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	17.61	7.65	7.88	0.93	0.93	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	4.27	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	14.80	9.97	4.11	0.72	0.31	0.51
mesothelioma cell line:Mero-25	10850-111F4	8.85	6.58	2.95	2.50	0.68	0.00
mesothelioma cell line:Mero-41	10851-111F5	65.52	19.80	9.78	5.38	0.98	0.98
mesothelioma cell line:Mero-48a	10852-111F6	38.53	19.71	9.30	1.77	0.89	1.77
mesothelioma cell line:Mero-82	10853-111F7	19.45	10.78	6.31	1.58	0.53	0.53
mesothelioma cell line:Mero-83	10854-111F8	16.85	15.15	5.45	2.04	0.34	1.53
mesothelioma cell line:Mero-84	10855-111F9	17.69	6.82	3.29	0.51	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	23.40	10.97	7.25	1.45	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	60.30	18.39	10.27	0.83	0.99	0.33
mesothelioma cell line:NCI-H226	10846-111E9	37.47	6.52	8.87	0.18	0.18	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	44.24	14.86	10.42	4.61	1.20	3.07
mesothelioma cell line:NCI-H28	10845-111E8	20.10	14.76	5.34	7.89	1.53	0.76
mesothelioma cell line:No36	10857-111G2	26.42	20.88	5.22	2.61	0.65	0.65
mesothelioma cell line:ONE58	10858-111G3	41.46	18.97	13.28	1.35	0.81	0.81
migratory langerhans cells, donor1	11901-125F2	24.57	15.93	9.98	4.80	0.96	0.00
migratory langerhans cells, donor2	11902-125F3	20.03	15.02	8.43	4.64	0.49	0.98
migratory langerhans cells, donor3	11903-125F4	24.77	11.49	8.97	4.31	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	73.78	37.22	13.06	5.55	1.63	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.27	7.42	5.09	2.97	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	20.96	8.75	6.91	5.07	0.69	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11.99	13.13	4.00	7.80	0.57	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	72.25	29.94	8.69	11.27	2.40	1.66
myeloma cell line:PCM6	10474-106I6	3.95	2.17	1.38	6.92	0.40	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	17.25	7.10	4.06	1.01	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	18.44	10.59	3.53	2.35	0.78	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.23	3.23	2.67	7.58	0.22	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	3.31	4.85	2.65	7.06	0.66	0.37
nasal epithelial cells, donor2	12227-129F4	6.62	11.04	7.18	3.31	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	65.80	31.06	11.04	15.41	5.06	2.30
neuroblastoma cell line:NB-1	10539-107G8	19.83	16.84	5.43	11.97	2.99	1.50
neuroblastoma cell line:NBsusSR	10607-108F4	59.47	156.27	28.26	13.92	5.48	4.64
neuroblastoma cell line:NH-12	10555-107I6	80.88	41.93	10.44	13.60	2.61	2.24
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	64.76	86.59	7.35	2.37	3.32	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	57.97	55.27	11.88	8.39	1.58	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	11.07	5.03	1.01	5.23	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	32.42	6.99	5.09	3.81	1.27	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	5.86	2.40	2.93	4.26	0.00	0.27
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	253.51	44.31	16.40	16.57	3.04	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	14.41	9.61	5.60	6.40	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	7.37	6.73	3.53	6.09	0.64	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	6.83	6.31	3.68	5.26	0.53	0.53
nucleus accumbens, adult, pool1	10037-101F1	99.55	91.58	40.21	10.78	5.34	4.69
occipital cortex - adult, donor10196	10172-103C1	103.02	121.56	18.54	10.30	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	114.86	129.89	26.57	9.39	9.39	0.54
occipital cortex, newborn, donor10223	10355-105E4	559.75	114.64	49.86	7.28	6.55	9.83
occipital lobe, adult, donor1	10076-102A4	47.23	51.43	16.53	9.71	2.89	2.62
occipital lobe, fetal, donor1	10073-102A1	23.17	40.34	7.29	5.15	3.43	0.86
occipital pole, adult, pool1	10036-101E9	41.23	49.75	17.98	5.76	2.21	2.37
olfactory region, adult	10195-103E6	43.37	48.53	12.42	6.69	2.87	1.15
optic nerve, donor1	10277-104E7	20.01	16.01	0.00	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	26.20	21.30	10.71	4.90	1.82	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	190.97	39.70	29.54	7.83	1.79	2.06
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	24.21	10.67	8.80	7.62	0.51	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	57.52	7.16	17.44	4.39	0.92	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	9.70	5.00	3.82	3.23	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	19.62	13.08	14.02	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	49.62	23.54	7.85	6.36	3.39	0.85
ovary, adult, pool1	10020-101D2	31.80	20.61	6.03	6.90	1.22	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	18.15	8.62	4.40	1.83	0.37	1.28
pancreas, adult, donor1	10049-101G4	18.81	7.53	2.82	3.76	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	48.64	11.46	6.15	5.03	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	33.39	19.08	9.03	2.04	1.36	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	31.13	25.83	8.61	2.15	0.83	0.00
paracentral gyrus, adult, pool1	10035-101E8	75.96	65.90	23.89	9.24	4.76	2.84
parietal cortex, adult, donor10258	10373-105G4	58.72	47.71	20.55	5.87	2.20	3.67
parietal lobe - adult, donor10196	10171-103B9	58.31	79.94	13.17	4.70	0.94	4.70
parietal lobe, adult, donor10252	10157-103A4	97.77	113.44	23.94	11.69	4.28	1.43
parietal lobe, adult, pool1	10034-101E7	59.48	62.21	20.80	7.49	4.23	2.82
parietal lobe, fetal, donor1	10072-101I9	27.16	42.67	9.70	8.73	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	811.65	95.71	41.50	5.61	6.73	8.60
parotid gland, adult	10199-103F1	6.78	5.55	1.23	4.32	0.00	0.00
penis, adult	10200-103F2	20.95	8.59	3.22	4.83	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	148.75	40.16	17.48	3.90	0.19	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	42.11	10.34	8.74	4.66	0.44	0.58
pineal gland - adult, donor10196	10179-103C8	29.03	28.38	3.23	2.58	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	128.51	131.47	16.58	32.57	7.11	0.59
pineal gland, adult, donor10258	10377-105G8	23.20	16.93	3.14	5.64	1.88	0.63
pituitary gland - adult, donor10196	10180-103C9	48.57	38.45	5.06	12.14	6.07	1.01
pituitary gland, adult, donor10252	10162-103A9	157.92	106.32	25.54	33.88	5.73	2.61
pituitary gland, adult, donor10258	10378-105G9	42.56	18.73	5.11	11.07	2.55	1.70
placenta, adult, pool1	10021-101D3	12.58	8.28	2.15	4.19	0.22	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	41.98	16.55	11.65	4.24	2.12	1.19
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	8.25	8.87	3.58	2.80	0.93	0.00
pons, adult, pool1	10033-101E6	77.80	40.19	13.25	5.25	3.61	3.36
postcentral gyrus, adult, pool1	10032-101E5	47.51	54.83	16.30	5.93	3.05	2.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	10.46	8.37	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	7.14	5.54	5.10	2.77	0.73	0.73
prostate cancer cell line:PC-3	10439-106E7	34.67	12.71	10.16	8.17	2.18	1.27
prostate, adult, pool1	10022-101D4	60.76	25.85	7.26	6.62	1.18	0.18
putamen, adult, donor10196	10176-103C5	162.18	169.26	83.80	11.57	10.15	4.25
putamen, adult, donor10252	10152-102I8	105.88	94.11	37.25	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	33.88	49.18	24.04	3.28	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	79.73	95.20	41.80	6.52	3.14	5.32
putamen, newborn, donor10223	10365-105F5	403.32	88.46	40.48	9.00	5.25	6.75
rectal cancer cell line:TT1TKB	10469-106I1	40.73	30.55	14.84	7.27	1.45	0.00
rectum, fetal, donor1	10067-101I4	18.08	2.78	1.39	4.17	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	12.72	9.54	7.21	5.51	0.64	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	1.24	2.07	2.07	1.66	0.00	0.00
retina, adult, pool1	10030-101E3	16.30	8.25	1.39	4.77	0.80	0.10
retinoblastoma cell line:Y79	10475-106I7	11.69	6.24	3.12	13.51	0.26	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	26.93	21.64	9.10	11.19	1.97	5.04
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	23.62	8.72	3.37	29.24	0.56	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	11.37	5.30	3.79	3.03	0.00	0.00
salivary acinar cells, donor1	11771-123I7	24.60	4.37	7.12	3.24	0.81	0.49
salivary acinar cells, donor2	11772-123I8	21.75	7.85	3.99	2.62	0.83	0.28
salivary acinar cells, donor3	11773-123I9	37.74	15.89	12.58	1.32	0.00	0.66
salivary gland, adult, pool1	10093-102C3	13.15	6.86	2.86	2.86	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	68.04	25.21	11.89	9.19	1.69	2.87
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	65.95	24.33	11.76	8.58	2.00	2.47
seminal vesicle, adult	10201-103F3	73.54	17.99	10.05	5.29	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	42.03	25.99	13.85	7.29	1.70	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.83	9.31	3.27	0.75	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	52.18	19.07	14.05	3.01	0.00	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	22.97	19.21	4.57	0.81	0.40	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	28.63	13.37	11.16	4.31	0.22	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	36.64	12.00	11.87	3.48	1.03	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	12.06	11.35	2.13	2.13	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	16.07	10.79	3.00	5.28	0.72	0.12
skeletal muscle, fetal, donor1	10066-101I3	8.04	6.03	0.00	4.02	0.00	0.00
skin, adult, donor1	10074-102A2	6.79	0.00	6.79	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	17.67	6.94	2.52	5.68	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	23.01	10.67	3.67	7.67	1.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	19.23	14.81	5.04	4.73	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	31.42	26.98	3.47	9.83	1.73	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	12.69	6.10	3.13	6.43	1.15	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	18.18	7.56	1.61	10.13	0.48	1.45
small cell lung carcinoma cell line:WA-hT	10562-108A4	29.20	14.60	10.46	7.19	0.22	1.96
small intestine, adult, pool1	10024-101D6	13.86	9.08	4.42	5.37	0.24	0.00
small intestine, fetal, donor1	10064-101I1	10.56	4.91	3.44	4.42	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	130.79	27.70	24.11	9.23	2.05	1.03
smooth muscle, adult, pool1	10048-101G3	23.52	13.18	3.36	5.69	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	13.67	5.90	5.90	4.56	1.07	0.00
spinal cord - adult, donor10196	10181-103D1	29.13	25.92	2.98	4.82	0.92	0.23
spinal cord, adult, donor10252	10159-103A6	213.30	95.02	12.62	10.65	6.70	0.00
spinal cord, adult, donor10258	10369-105F9	31.82	17.29	1.38	4.84	0.00	1.38
spinal cord, fetal, donor1	10056-101H2	21.34	12.20	6.71	6.71	2.44	1.83
spinal cord, newborn, donor10223	10359-105E8	149.24	50.05	10.10	1.84	0.92	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	9.86	5.38	3.58	2.69	0.75	0.30
spleen, adult, pool1	10025-101D7	13.11	9.69	4.19	6.50	0.77	0.00
spleen, fetal, pool1	10044-101F8	231.85	22.41	12.00	4.13	1.43	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	42.75	16.25	8.18	3.31	1.55	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	25.06	10.63	5.13	6.08	0.95	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	7.34	5.59	2.45	4.54	0.70	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	22.67	8.60	8.60	3.91	1.17	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	7.65	6.42	6.19	5.97	0.68	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	44.48	15.25	3.81	2.12	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	49.08	19.46	10.15	3.81	0.42	0.42
stomach, fetal, donor1	10062-101H8	19.22	4.27	3.20	4.27	0.00	0.00
submaxillary gland, adult	10202-103F4	23.36	10.25	5.13	3.42	3.42	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	169.49	116.73	9.55	9.76	7.48	0.21
substantia nigra, adult, donor10258	10371-105G2	70.35	31.55	7.76	3.10	0.52	2.07
substantia nigra, newborn, donor10223	10358-105E7	144.85	20.49	3.53	2.83	2.12	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	84.37	57.09	27.97	13.99	4.13	1.38
temporal lobe, adult, pool1	10031-101E4	40.35	44.84	14.33	7.04	2.80	1.61
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	17.09	32.05	4.99	4.99	4.27	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	14.07	35.16	4.83	5.27	1.76	1.32
tenocyte, donor1	11763-123H8	11.52	5.59	2.09	5.24	0.35	0.35
tenocyte, donor2	11765-123I1	6.10	6.10	1.91	1.91	0.00	0.00
tenocyte, donor3	11768-123I4	8.15	5.56	2.22	3.71	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	47.25	18.19	8.67	14.11	1.36	3.57
teratocarcinoma cell line:NCR-G1	10798-110I6	6.01	4.16	0.62	7.55	0.15	0.15
teratocarcinoma cell line:PA-1	10807-111A6	20.92	13.64	4.96	7.90	1.24	1.70
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	72.36	27.17	11.17	7.11	1.65	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	340.73	41.98	18.91	6.43	4.54	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	327.62	35.77	15.05	11.56	1.85	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	44.30	20.52	7.49	8.79	2.93	0.33
testis, adult, pool1	10026-101D8	39.94	26.09	6.76	19.86	3.65	10.74
testis, adult, pool2	10096-102C6	37.89	20.30	4.06	15.34	1.35	13.98
thalamus - adult, donor10196	10168-103B6	80.59	51.89	13.25	9.94	2.21	1.10
thalamus, adult, donor10252	10154-103A1	135.97	140.65	18.75	11.56	7.97	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	66.20	83.14	20.02	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	49.90	22.23	9.06	1.65	1.32	0.66
thalamus, newborn, donor10223	10366-105F6	424.59	56.38	43.72	2.30	3.45	3.45
throat, adult	10209-103G2	49.68	16.23	4.24	4.99	1.25	0.00
throat, fetal, donor1	10061-101H7	17.06	11.27	3.35	2.74	1.52	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	58.82	28.02	9.54	9.14	2.58	0.99
thymus, adult, pool1	10027-101D9	34.80	31.61	12.13	8.15	2.29	0.20
thymus, fetal, pool1	10043-101F7	856.80	48.42	38.76	6.23	3.12	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	56.24	19.41	11.97	3.72	1.06	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	15.92	5.03	5.59	5.73	0.56	0.42
thyroid, adult, pool1	10028-101E1	101.43	45.82	13.06	11.29	2.52	0.56
thyroid, fetal, donor1	10060-101H6	22.94	11.60	1.58	7.65	1.32	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	6.16	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	23.26	14.88	3.49	4.42	0.93	0.23
tongue, fetal, donor1	10059-101H5	12.22	12.61	1.58	5.12	0.79	0.00
tonsil, adult, pool1	10047-101G2	39.57	14.22	5.81	5.11	0.70	0.00
trachea, adult, pool1	10029-101E2	94.07	38.69	15.62	7.85	3.03	0.74
trachea, fetal, donor1	10058-101H4	79.63	12.69	3.46	3.46	1.15	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	26.22	7.79	5.31	2.48	0.71	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	65.96	43.16	18.95	11.04	1.62	1.11
transitional-cell carcinoma cell line:JMSU1	10492-107B6	35.10	15.36	9.24	9.71	2.51	1.41
tridermal teratoma cell line:HGRT	10694-109G1	3.81	3.81	1.90	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	20.91	9.31	7.36	4.15	0.42	0.25
umbilical cord, fetal, donor1	10057-101H3	12.52	2.09	0.00	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	61.43	17.57	6.31	7.51	0.34	0.34
uterus, fetal, donor1	10055-101H1	27.64	13.31	6.14	3.58	0.51	0.51
vagina, adult	10204-103F6	1448.78	186.75	74.96	6.46	3.23	1.29
vein, adult	10191-103E2	31.56	12.71	4.82	3.73	1.32	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.08	6.41	5.34	3.74	0.53	0.53